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General introduction and 
aim of this thesis
General introduction and aim of this thesis 
This thesis focuses on studies to improve the Dutch practice of caesarean sections (CS), with 
valid quality indicators as a basis. This introduction starts with a brief history of CS, after 
which we will discuss both the short-term and the long-term consequences of this operation. 
Next, the unplanned (emergency) CS and vaginal birth after CS (VBAC) will be discussed. This 
chapter concludes with the outline of this thesis. 
History of CS
Originally, the CS was an operation performed on a dead or dying mother, probably because 
of religious beliefs, since mother and child had to be buried separately. Although it is 
commonly believed to be derived from the surgical birth of Julius Caesar in July 100 BC, this 
seems highly unlikely because his mother Aurelia survived the procedure and she is known 
to have been aware of her son’s invasion of Britain in 55 BC [1].
The birth of Julius Caesar. From Suetonius’ Lives of the Twelve Caesars, 1506 woodcut.
The first written record of a surviving mother and baby is from Switzerland in 1500, where 
Jacob Nufer performed a CS on his wife. After several days in labour, and despite the help 
of 13 midwives, Jacob got permission from the local authorities to perform the operation. 
The mother survived and had 5 vaginal births thereafter. However, historians question the 
accuracy of this story, since it was recorded 82 years later. Thus, the precise date of the first 
CS is not certain. 
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Although many cultures refer to a CS for non-progressing labour in pelvic anomalies or 
abnormal foetal presentation, it was an unsafe procedure due to lack of knowledge of 
anatomy, lack of anaesthesia and risks of major bleeding and infection. 
CS rates
In the Netherlands in 1900, 1.8% of all deliveries took place in hospital. A CS was performed 
in 0.7% of delivering women, with a maternal and neonatal mortality rate of 12% and 2%, 
respectively [1]. A lot has changed since those days. We are now faced with a worldwide rise 
in caesarean section (CS) rates. Although the Netherlands has a relatively low CS rate (16.7%) 
compared to the United Kingdom (24.6%) and the United States (32%), the most impressive 
rise in CS rate is found in ‘low risk pregnancies’: healthy women with a singleton in cephalic 
position at term [2-5]. The World Health Organization estimates a CS rate between 10–15% 
to be optimal [6]. Despite this suggested optimal CS rate, the Euro-Peristat study showed 
CS percentages in Europe ranging from 14.8 to 52.2%, without evidence of improved foetal 
outcome with increasing CS rate (Figure 1) [7]. 
Figure 1: European CS rate, Europeristat Group [7]
Nowadays a CS is considered to be a relatively safe procedure, but it is still associated 
with increased short-term morbidity and mortality, with an increased risk of abnormal 
placentation, and uterine rupture in future pregnancies [8,9]. Furthermore, rising CS rates 
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are not associated with improved outcome for mother and neonate [10-12]. A CS costs twice 
as much as a vaginal delivery, 1256 euros to 9652 euros extra depending on the country of 
origin [13]. Adding all costs of future morbidity and the increased risk of future repeat CS, the 
estimated additional costs of one CS are 7500 euros.
Previous studies mostly focused on epidemiological data such as rising maternal age, 
maternal request for CS, and the decline in attempt of VBAC [14,15]. Applying the Robson 
Ten-Group Classification System, others mainly identified the nulliparous single cephalic term 
pregnancy, as well as the women with a previous CS to be the most important contributors to 
the total CS rate [16,18]. Prevention of unnecessary, unplanned CS in nulliparous women will 
have an effect on both current and future pregnancies. Therefore, more insight is needed in 
factors influencing the unplanned CS rates in this group of women.
Quality of care
Through the years several international obstetrical organizations developed evidence-based 
guidelines with recommendations for optimal care regarding the decision when to perform 
a CS. However, the crucial issue remains whether these recommendations are actually 
followed. In order to improve current CS practice, it is of importance to gain insight into the 
extent of guideline implementation in daily practice and the factors that improve or hinder 
guideline implementation. Before this can be measured, valid quality indicators for optimal 
care have to be systematically developed [19,20]. The model of Grol et al., describes the 
steps necessary to develop, test and evaluate a strategy to implement guidelines. These 
steps for CS practice are specified below. 
Step 1. Description of evidence based recommendations on CS practice
Quality indicators can be used to asses CS practice. Lawrence et al. defined quality indicators 
as ‘measurable elements of practice performance for which there is evidence or consensus 
that they can be used to assess the quality, and hence change in the quality, of care provided’ 
[21]. Recommendations on CS practice from national and international guidelines and 
literature will be evaluated by an expert panel consisting of obstetricians and midwives. 
Step 2. Assessment of actual CS practice
Vankan et al. showed that in 21 Dutch hospitals elective repeat CS rates varied between 7 
and 51%. Vaginal birth after CS rates ranged from 53 to 90%. More than 85% of practice 
variation could not be explained by risk factors at patient level. A lack of guideline adherence 
might play a role in this practice variation. The developed quality indicators on CS practice 
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will be used to gain insight into current CS practice in 21 Dutch hospitals. 
Step 3. Identification of barriers and facilitators
Besides insight into quality indicators and current CS practice, insight into facilitators and 
barriers among all professionals involved in CS decision-making is essential. This insight can 
support the development of a tailored strategy to overcome barriers and improve guideline 
implementation. Barriers and facilitators for CS practice will be explored among midwives, 
obstetrical residents and obstetricians at different domains described by Grol: features of 
guideline recommendations, professionals and patients, as well as the social, organizational 
and financial context [22].
Step 4-5. Improving CS practice
Insight into current CS practice and into the hindering and facilitating factors influencing 
obstetrical policy on CS is essential to improve CS practice. It will allow definition of groups of 
women where a tailor-made implementation strategy will most likely be meaningful and cost 
effective, without negatively affecting the outcome for mother and child.
Measures that influence the CS rate are directed at 1) planned CS with a questionable 
indication for CS, 2) counselling of women when a CS and a vaginal delivery are both more or 
less equal options and 3) prevention of unplanned CS when a vaginal delivery is the normal 
policy. At this moment, it is unclear which situations are most urgent to tackle. The aim is 
to first identify women with clinical situations that occur regularly (e.g. discussing the role 
of a CS in triplets will not reduce the total amount of unnecessary CS), and/or in whom 
current care deviates substantially from the optimal care. Secondly, when a group of women 
is identified in whom a discrepancy exists between current care and optimal care and in 
whom barriers for optimal care are identified, an intervention strategy can be developed. For 
example: in cases with a breech presentation, most guidelines advise an external version. 
A possible finding could be that the CS rate for breech presentation is far too high because 
an external version is not (adequately) performed. Training and education of inexperienced 
caregivers can then be a useful strategy. In order to improve CS care, we will identify those 
women with situations that occur regularly and also have a low adherence rate. 
Aim of this thesis
This thesis focuses on studies to improve CS care. The aim is to identify groups of women 
in whom provided care is frequently not according to the evidence based guidelines, using 
guideline-based quality indicators, to identify barriers and facilitators for guideline non-
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adherence and to get insight into those groups of women in whom improvement is likely to 
be (cost) effective and feasible. We aim to answer the following questions:
1) What is optimal CS care? (Chapter 3)
a) Regarding planned CS: 
In which situations
- is a CS advised?
- is a CS an equal option to a vaginal delivery?
- is a vaginal delivery the normal policy?
b) Regarding unplanned CS:
Which preventive measures are advised to optimize the chance of a vaginal 
delivery?
2) What is the adherence to the recommendations in current care and which women are 
most likely to benefit from an intervention? (Chapter 3)
How many women:
a) are confronted with a specific clinical situation (frequency of occurrence and 
relevance for general care)?
b) receive optimal care (adherence to quality indicators) ? 
3) What are factors hindering or helping professionals to provide optimal care to women? 
(Chapter 4)
4) Which factors (medical and non-medical) influence the unplanned (emergency) CS rate 
in nulliparous women? (Chapter 5,6)
14 
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Abstract
Background         
Caesarean section (CS) rates are rising worldwide. In the Netherlands, the most significant 
rise is observed in healthy women with a singleton in vertex position between 37 and 42 
weeks gestation, whereas it is doubtful whether an improved outcome for the mother or 
her child was obtained. It can be hypothesized that evidence-based guidelines on CS are not 
implemented sufficiently.        
Therefore, the present study has the following objectives: to develop quality indicators on 
the decision to perform a CS based on key recommendations from national and international 
guidelines; to use the quality indicators in order to gain insight into actual adherence of 
Dutch gynaecologists to guideline recommendations on the performance of a CS; to explore 
barriers and facilitators that have a direct effect on guideline application regarding CS; and 
to develop, execute, and evaluate a strategy in order to reduce the CS incidence for a similar 
neonatal outcome (based on the information gathered in the second and third objectives).
Methods              
An independent expert panel of Dutch gynaecologists and midwives will develop a set of 
quality indicators on the decision to perform a CS. These indicators will be used to measure 
current care in 20 hospitals with a population of 1,000 women who delivered by CS, and a 
random selection of 1,000 women who delivered vaginally in the same period. Furthermore, 
by interviewing healthcare professionals and patients, the barriers and facilitators that may 
influence the decision to perform a CS will be measured. Based on the results, a tailor-made 
implementation strategy will be developed and tested in a controlled before-and-after 
study in 12 hospitals (six intervention, six control hospitals) with regard to effectiveness, 
experiences, and costs.
Discussion           
This study will offer insight into the current CS care and into the hindering and facilitating 
factors influencing obstetrical policy on CS. Furthermore, it will allow definition of patient 
categories or situations in which a tailor-made implementation strategy will most likely be 
meaningful and cost effective, without negatively affecting the outcome for mother and child.
20 
CHAPTER 2
2
Background            
This study will offer insight into the current CS care and into the hindering and facilitating 
factors influencing obstetrical policy on CS. Furthermore, it will allow definition of patient 
categories or situations in which a tailor-made implementation strategy will most likely be 
meaningful and cost effective, without negatively affecting the outcome for mother and child.
The worldwide rise in caesarean section (CS) rate is a major healthcare issue, with rates 
reported as high as 32% in the United States (US) and 37% in Brazil. [1,2]. In the Netherlands, 
the overall CS rate has increased from 8.1% to 13.6% over the recent decade. Although this 
rise is relatively low compared to other countries, a striking detail is that the most impressive 
rise, in absolute numbers, was among healthy women with a singleton in vertex position 
between 37 and 42 weeks gestation [3]. However, an increasing CS rate does not imply an 
improved outcome for mother and infant [4]. CS are associated with an increased risk of 
maternal mortality as well as serious morbidity, such as admission to the intensive care unit 
(Odds Ratios (ORs) between 30.8 and 63.4), hysterectomy (ORs between 3.2 and 13.5), and 
puerperal infection (OR 3.0) [5-7].
Besides the short-term risks, CS have an impact on the mother’s future reproductive health, 
for example uterine rupture, placenta praevia, or placenta accreta [8,9].
There is no evidence suggesting a better neonatal outcome from the increased CS rate in terms 
of mortality, intracranial haemorrhage, or impaired neurological development in the general 
population [10,11]. In fact, an elective CS performed before 39 completed weeks is associated 
with respiratory distress and admission to the neonatal intensive care unit [11,12].
The question arises what causes the worldwide increase in CS rate considering the fact that in 
most situations there are no apparent benefits of a CS for mother and child; the costs are higher 
compared to vaginal birth [5]; and the incidence of both maternal and neonatal complications 
are increased. There are concerns about the increasing rate of planned CS as well as a declining 
rate of vaginal birth after a previous CS (VBAC) in the US and Australia [13,14].
To optimize CS practice, the Royal College of Obstetricians and Gynaecologists (RCOG) 
developed an evidence-based guideline (NICE: National Institute of Clinical Evidence) with 
clear recommendations for obstetric care. Similar recommendations, which have a direct effect 
on the decision to perform a CS, are also mentioned in the different guidelines of the Dutch 
Society of Obstetrics and Gynaecology (NVOG), Society of Obstetricians and Gynaecologists 
of Canada (SOGC), American College of Obstetrics and Gynaecology (ACOG), and National 
Guideline Clearinghouse from the US department of health and human services (NGC).
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Despite the introduction of evidence-based guidelines, the CS rate continues to increase. We 
hypothesize that poor adherence to the guidelines plays a key role in the rising CS rate. In 
order to optimize adherence to the CS guidelines, the stepwise model by Grol can be used 
to select the proper strategies [15,16]. The first step in this model is to analyze the current 
care (measured by valid quality indicators) compared to the optimal care as described in 
evidence-based guidelines, and to determine which barriers and facilitators might influence 
the implementation of optimal care. Subsequently, a tailor-made implementation strategy 
can be developed with activities applied to the determined barriers. In the last step, the 
strategy is executed and evaluated in terms of effectiveness, feasibility, and costs.
In view of the rising CS rate, this study aims are:
1. To develop a set of quality indicators on the decision to perform a CS based on key 
recommendations of both Dutch and international guidelines.
2. To gain insight into actual adherence of Dutch gynaecologists to guideline 
recommendations on the performance of CS.
3. To explore barriers and facilitators that have a direct effect on application of guideline 
recommendations regarding CS.
4. To develop, execute and evaluate a strategy in order to improve care and possibly 
decrease the CS incidence for a similar neonatal outcome, based on the information 
gathered in steps two and three.
Methods
The four aims were approached in four parts: the development of quality indicators, 
the assessment of current t care, the identification of barriers and facilitators, and the 
development of a tailored implementation strategy and executing and evaluating this 
strategy in a clustered controlled before-and-after study (CBA).
The development of quality indicators
Design and methods           
In order to measure current Dutch practice on CS, quality indicators regarding the process, 
structure, and outcome of care need to be developed. This will be achieved according to the 
RAND-modified Delphi method [17,18]. The indicators will be based on key recommendations 
extracted from the guidelines of several international obstetric organisations (RCOG, NVOG, 
SOGC, ACOG and NGC). These key recommendations will be evaluated in two rounds by an 
independent expert panel consisting of Dutch obstetricians and midwives. In the first round, a 
questionnaire will be developed on three subjects (planned CS, emergency CS, and methods 
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to reduce the CS rate). The questionnaire will be sent to the experts who will be asked to 
individually rate the key recommendations on a 9-point Likert scale ranging from 1 to 9 (‘not 
relevant’ to ‘extremely relevant’ for measuring the quality of CS care). Furthermore, a ranking 
of the key recommendations will be asked per subject to ultimately extract those indicators 
considered to be most important for quality-of-care measurement. The experts also have the 
opportunity to add comments or suggest additional recommendations they consider suitable 
as a quality indicator. The returned questionnaires will be analysed based on the ratings 
of the recommendations on the 9-point Likert scale, and the median score of these items 
will be calculated and rated as described previously by Campbell [19]. Furthermore, scoring 
variables reflecting the ranking of the items in each of the three subjects will be developed 
(e.g., in a top 3 ranking, a first ranking creates 3 points, a second ranking 2 points, and a third 
ranking 1 point).
The second round consists of a consensus meeting where the experts will receive their 
individual as well as the overall results of the first round to promote discussion. The aim of this 
meeting is to reach consensus on those recommendations that are most suitable for assessing 
the quality of care on performing CS. After consensus is reached, the recommendations will 
be operationalized into a set of measurable quality indicators.
Study population and setting           
A representative, national expert panel consisting of obstetricians and midwives (about 12 to 
15 experts) will be invited. The obstetricians and midwives will have worked at various types 
of hospitals, ranging from small regional hospitals to university hospitals.
Outcome measures          
The outcome of the first step of the study is a set of valid quality indicators regarding the 
decision to perform a CS which can then be used to measure the current practice.
The assessment of current care
Design and methods           
A retrospective medical record search based on the set of quality indicators will be 
performed in order to assess the Dutch gynaecologists’ adherence to the CS guideline 
recommendations. Adherence to these indicators will be quantified, as well as the variation 
in care and adherence between the participating hospitals. To gain insight into the current 
Dutch care compared to international care, the CS percentages of the different risk groups 
will be calculated according to the Robson classification (Table 1) [20]. Furthermore, the 
maternal mortality or severe acute morbidity (Table 2) [21], and perinatal mortality or 
serious morbidity (pH <7.00, Apgar 5 min <7, and NICU admission) will be noted. This study 
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will provide us with information about current practice on CS in the Netherlands and insight 
into the effects on outcome of mother and child.
Table 1. Ten-group classification according to Robson
Groups:
1. Nulliparous, single cephalic, >37 weeks, in spontaneous labour
2. Nulliparous, single cephalic, >37 weeks, induced or CS before labour
3. Multiparous (excluding previous CS), single cephalic, >37 weeks, in spontaneous labour
4. Multiparous (excluding previous CS), single cephalic, >37 weeks, induced or CS before labour
5. Previous CS, single cephalic, >37 weeks
6. All nulliparous breeches
7. All multiparous breeches (including previous CS)
8. All multiple pregnancies (including previous CS)
9. All abnormal lies (including previous CS)
10 All single cephalic, < 36 weeks, (including previous CS)
Table 2. Inclusion criteria for severe acute maternal morbidity     
Group 1: ICU admission
- Admission to ICU or coronary care unit, other than for standard postoperative recovery
Group 2: Uterine rupture
- Clinical symptoms (pain, fetal distress, acute loss of contractions and haemorrhage) that led to an emergency CS, at which 
the presumed diagnosis of uterine rupture was confirmed
- Peripartum hysterectomy or laparotomy for uterine rupture
Group 3: Eclampsia/ HELLP syndrome
- Eclampsia
- HELLP syndrome only when accompanied by liver haematoma or rupture
Group 4: Major obstetric haemorrhage
- Transfusion need of > 4 units of packed cells
- Embolisation or hysterectomy for major obstetric haemorrhage
Group 5: Miscellaneous
- Other cases of severe maternal morbidity to the opinion of the treating obstetrician, not to be included in group 1-4
Study population and setting     
In order to create a representative view of the current obstetrical care in The Netherlands, a 
multi-centre study will be carried out. Twenty hospitals of different Dutch regions will participate 
in this study, including university teaching hospitals, non-university teaching hospitals and non-
university, non-teaching hospitals. The present study will take place in the setting of a Dutch 
Obstetric Research Consortium in which all the participating hospitals collaborate.
In the participating hospitals, data on basic obstetrical care and adherence to the quality 
indicators will be collected. Per hospital 100 women will be selected from the local database: 
50 women who delivered by CS and a random set of 50 women who delivered vaginally in the 
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same time period. Exclusion criteria will be a major fetal congenital malformality and fetal 
death prior to onset of delivery.
Outcome measures
The main outcome is adherence to the guideline recommendations, based on the adherence 
to the quality indicators. Therefore, basic obstetrical data and indicator specific data will 
be gathered. For example, consider the indicator ‘every woman with a child in breech 
presentation at 34 to 36 weeks gestation should be offered external cephalic version unless a 
contraindication for external cephalic version is present.’ This implies that we need to assess 
the incidence of breech presentation at 34 to 36 weeks gestation, as well as data that show 
whether an external cephalic version is being offered. Furthermore, we will note in which 
cases this procedure was not offered for a valid reason. This will allow us to determine the 
frequencies of adherence for this indicator.        
The secondary outcomes are the number of preventable CS, and Dutch practice as compared 
to international data using the Robson criteria.
Sample size considerations 
Assuming an adherence to the guidelines of 75%, an alpha of 0.05, and a precision of the 
estimation of 5%, 300 patients must be included. However, this number has to be adapted 
to take clustering of data across clinicians and within obstetrical departments into account. 
Assuming an intra-cluster correlation (ICC) of 0.2 and 80 professionals in 20 hospitals, 
960 medical records need to be analysed. In order to compensate for loss to follow-up or 
incomplete data, 1,000 women with a CS will be included in 20 hospitals within a timescale 
of three to four months. In order to enable the calculation of specific events, as described in 
‘outcome measures,’ a random selection of 1,000 women with a vaginal birth will be included. 
Thus, there will be 2,000 participants, i.e., 1,000 women after a caesarean delivery and 1,000 
women after a vaginal birth. Sampling fraction will be adjusted to the fraction of women with 
CS in each individual hospital.
Data analysis
The frequencies of adherence per quality indicator will be calculated. This will be calculated 
by dividing the total number of women who apply for an indicator and for whom care 
was appropriate by the total number of women who apply for an indicator. For example, 
women with a child in breech presentation between 34 to 36 weeks of gestation, without 
contraindication for external cephalic version, should have been offered an external cephalic 
version. Adherence is the total number of women with a child in breech presentation 
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between 34 to 36 weeks of gestation without contraindication for external cephalic version, 
in whom an external version was offered, divided by the total number of women with a child 
in breech presentation between 34 to 36 weeks of gestation without contraindication for 
external cephalic version.
Barrier and facilitator study
Design and methods
To determine the barriers and facilitators that influence the decision to perform a CS for 
healthcare professionals and patients, a qualitative study will be performed. The setting 
for guideline implementation will be analysed. Focus group interviews will be held among 
healthcare professionals (obstetricians, residents, and midwives) to discover factors that 
determine the decision to perform a CS or not. The interviewer will explore the following 
categories of influencing factors: features of the guidelines itself; features of the target group 
of professionals who should use the guidelines; features of patients who have to accept or 
contribute to the use of the guidelines; features of the social setting and social network of 
the professionals; and features of the organizational, economic, and administrative context. 
Remarks by professionals will be classified into categories of potential determining factors 
following this theoretical framework. The ‘prevalence’ of the features mentioned in the 
focus group interviews will be quantified in a survey with questionnaires among the different 
professionals.
Similarly, depending on the outcome of the current care study, semi-structured interviews 
will be held with patients in a detailed study to discover relevant factors that influence the 
patients’ decision to choose a CS or vaginal delivery.
Study population and setting
In different hospital types (university, non-university teaching, and non-university non-
teaching hospitals) interviews will be held among healthcare professionals (obstetricians, 
residents and midwives) as well as patients. Focus group interviews among 8 to 12 healthcare 
professionals will be planned. To assess whether the factors mentioned in the focus group 
interviews are structural, the ́ prevalence´ of these factors will be assessed using a survey with 
questionnaires among obstetric gynaecologists, residents, and midwives in the Netherlands. 
The questionnaires will be sent to the professionals via email addresses we will obtain from 
the national professional organisations of both professions. Among patients, semi-structured 
interviews will be held. These patients will be selected in the abovementioned hospitals from 
the current care study. The interviews will be conducted with those women belonging to the 
non-adherence subgroups (such as breech, non-progressing labour, or maternal request) to 
whom a possible implementation should be directed. Approximately ten to fifteen women 
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will be interviewed until no new information emerges during the interviews.
Outcome measures
The main outcome measures are the barriers and facilitators for adherence to the quality 
indicators for performing a CS.
Data analysis
Using Atlas, the qualitative software package, a qualitative analysis will be performed on the 
barriers and facilitators that are presented in the interviews among healthcare professionals 
and patients. The transcribed interview will be marked and coded with barriers and facilitators 
according to the framework used to structure the interviews: features of the guidelines, 
professionals, patients, social setting, and organization. These influencing factors will be 
quantified among all Dutch gynaecologists and midwives by means of questionnaires. The 
analyses of the questionnaires will be descriptive (e.g., frequencies and means).
Controlled before-and-after study
Design and methods
Based on the results of the current care study and the barrier and facilitator study, one 
or more target groups for a tailor-made implementation strategy will be identified. Target 
groups will be selected with focus on women with both a high incidence of the indicator (our 
hypothesis is that this will include, for example, non-progressing labour and previous CS) and 
low indicator adherence.
A tailor-made implementation strategy will be developed in order to increase adherence to 
the CS quality indicators. This strategy will be executed and evaluated in a clustered CBA study 
in 12 hospitals (six intervention, six control hospitals) (see sample size calculation) in terms of 
effectiveness, experiences, and costs. It is likely that a strategy with different implementation 
elements is needed because several barriers for implementation of recommendations may 
exist at different levels. This will probably result in a combined intervention directed at the 
level of professionals, patients, and the organisation.
Study population and setting
The implementation strategy will be executed and evaluated in 12 hospitals (see sample 
size calculation) that also participated in the current care study: six intervention hospitals in 
which the newly developed strategy will be applied; and six control hospitals in which care 
as usual will be offered. In order to select these 12 hospitals, all 20 hospitals of the current 
care study will be categorized into university, non-university teaching, and non-university 
non-teaching hospitals (three categories). Within these three categories, possible hospital 
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pairs will be made based on pre-intervention adherence to quality indicators and CS rates, as 
measured in the current care study. To get a sample representative for the Dutch setting, in 
total two university hospitals, six non-university teaching hospitals and four non-university, 
non-teaching hospitals will be asked to participate. Subsequently, the participating hospitals 
have to be assigned to the intervention and control group. This will be done per stratum and 
based on geographic region. The evaluation will include an effect, process, and cost analysis. 
Just as in de current care study, the effects will be measured both at medical outcome level 
(i.e., CS rates and complication rates) and on guideline adherence level. Satisfaction with and 
applicability of the tailor-made implementation strategy for both patients and healthcare 
professionals will be measured in a process evaluation. Information regarding the process will 
be gathered in a qualitative study in the hospitals in which the implementation strategy was 
applied. Individual interviews will take place among the involved healthcare professionals 
and patients to gather data about experiences with the changed care. During the interview, 
they also will be asked about which elements of the tested strategy they specifically used 
to implement the evidence-based guidelines; how satisfied they are with the different 
elements; and their opinion about the feasibility of the different elements.
Furthermore, a cost analyses of the tested implementation strategy will take place with 
respect to three aspects: 1) the rate at which the guideline recommendations are already 
applied; 2) the costs of the implementation strategy (taking into account the development 
of the strategy, training of healthcare professionals, and possible extra costs regarding both 
time and medical costs) and 3) the effectiveness of the implementation strategy. 
In order to measure the effectiveness of the implementation strategy both the effects on 
medical outcome (i.e., CS rates, complication rates) and adherence to CS quality indicators 
will be measured. The cost-effectiveness of the implementation strategy will be expressed 
as the incremental costs per extra patient treated according to the CS quality indicators, 
compared to the ‘do-nothing’ strategy.
Outcome measures
The primary outcome is effectiveness of the implementation strategy, which is defined 
as the observed increase in adherence to the developed quality indicators with regard to 
the chosen target group (for example non-progressing labour or previous CS) between 
the intervention and control hospitals and the actual CS rates in both groups. Secondary 
outcome measures are experiences and satisfaction of healthcare providers and patients 
with the implementation strategy as well as applicability and costs.
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Sample size considerations
For a sample size calculation, the target group and the adherence to the quality indicators 
regarding this target group are necessary. These data will be available after performing 
the current care as well as the barrier study. Based on these data, the sample size can 
be calculated. In this calculation, we will take into account clustering of patients within 
professionals and hospitals. We expect most of the clustering at professional level and 
presume an inclusion of a number of professionals per hospital and a number of patients per 
professional. For pragmatic reasons, we will include at most 12 out of the 20 hospitals of the 
current care measurement. This sample of hospitals has to be representative for the Dutch 
setting, i.e., a total of two university hospitals, six non-university teaching hospitals, and four 
non-university, non-teaching hospitals.
Data analysis
To assess the effectiveness of the implementation strategy, the proportion of patients that are 
treated in accordance with the guidelines before and after implementation of the guidelines 
in both the intervention and control hospitals will be measured. Medical outcome measures 
will include CS rates and maternal as well as neonatal complications related to vaginal 
delivery or CS. Multilevel multivariate analysis will be carried out to assess the independent 
effect of the implementation strategy on adherence to the CS quality indicators and medical 
outcome measures. 
A qualitative descriptive analysis will be done in order to evaluate the process. Furthermore, 
by means of a questionnaire, the experiences of healthcare providers and patient satisfaction 
with the implementation strategy will be evaluated, and the outcomes will be descriptive.
The costs analysis will be performed from a healthcare perspective. The costs of the 
implementation process will be calculated on the basis of the time and materials invested 
based on activity-based costing (ABC) approach, focusing on activities performed with costs 
accumulated at the activity level(s) of the healthcare implementation processes. The costs 
of implementation of the guidelines and consolidation consist of personnel and material 
costs. The input of resources will be assessed by collecting volumes of consumed resources, 
and multiplying these by the price of each resource unit. For collecting information on the 
input of the resources, registration forms will be completed by the people involved in the 
implementation and consolidation process. The prices of each resource unit will be based 
on standard costs [22], market prices, or self-determined costs. The medical costs used in de 
cost analysis will include CS rates and maternal and neonatal complications related to vaginal 
delivery or CS. The costs of implementation and costs of the changed medical care will be 
weighed against the proportion of patients that are treated according to the CS guideline, 
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after implementation. The cost-effectiveness of implementation will be expressed as the 
incremental costs per extra patient treated according to the CS guideline, compared to the 
‘do-nothing’ strategy (i.e., no implementation, for which data before implementation will be 
used).
Ethical considerations
The Medical Ethical Committee (CMO) of Maastricht (azM/UM) declared that no ethical 
approval was necessary for this study protocol.
Discussion
The CS rate in The Netherlands is comparatively low compared to other countries, but it is 
increasing especially in the group of healthy women with a singleton pregnancy in vertex 
position at term. One would expect this to coincide with improved outcomes for mothers 
and children, which is, however, not the case [5]. Although many suggestions considering 
the reason for this rise have been made, the answer is not yet clear. We hypothesize that 
incomplete guideline adherence is a possible cause for the current increase in CS rate. In this 
study we will determine current Dutch care regarding CS using quality indicators. We will use 
national as well as international guidelines to select the recommendations, resulting in at 
least a set of internationally accepted indicators. 
Because we will also report the current CS rates by classification into the internationally 
accepted Robson Criteria, international comparison of incidences of CS rates in different 
subgroups will be possible. In that way, specific indicators and incidences of those indicators 
might be applicable elsewhere. Furthermore, we will focus on factors that influence guideline 
implementation, and thus optimal care in the barrier and facilitator analysis.
Although earlier reviews claimed that multifaceted strategies (combinations of many different 
interventions) are often effective, Grimshaw found that a higher number of intervention 
components was not related to higher effectiveness [23]. It seems plausible that combined 
interventions are only more effective than single interventions, if these are addressed at the 
specific barriers to change. This is also the conclusion of Chaillet et al.: in the obstetric setting 
in general and the CS setting in particular, prospective identification of efficient strategies 
and barriers to change is necessary to achieve a better adaptation of intervention and to 
improve clinical practice guideline implementation [24].
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This study will hopefully result in one or more target groups with high incidence and low 
guideline adherence and the evaluation of an implementation strategy to improve care. For 
example, non-progressing labour is known to be one of the major reasons to perform a CS. 
Should guideline adherence in these women be low, an intervention based both on informing 
women and reminders on optimal care for caregivers could be an option. Another possible 
target group might be women with a previous CS. Although in general, the VBAC rate was 
previously reported higher in the Netherlands than in some other countries, recent data are 
lacking. Improvement of care for these women could consist of a decision aid to improve 
counselling. Both types of interventions are also possibly effective outside the Netherlands. 
The ultimate aim of our study is to implement the national and international evidence-based 
guidelines on CS in all Dutch hospitals in order to reduce the incidence of CS and improve 
the outcome for mother and child. Furthermore, this study provides a framework for future 
studies to enable improvement of guideline adherence and reduction of the CS rate.
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Abstract
Background
There is an ongoing discussion on the rising CS rate worldwide. Suboptimal guideline 
adherence may be an important contributor to this rise. Before improvement of care can 
be established, optimal CS care in different settings has to be defined. This study aimed to 
develop and measure quality indicators to determine guideline adherence and identify target 
groups for improvement of care with direct effect on caesarean section (CS) rates. 
Method
Eighteen obstetricians and midwives participated in an expert panel for systematic CS quality 
indicator development according to the RAND-modified Delphi method. A multi-center study 
was performed and medical charts of 1024 women with a CS and a stratified and weighted 
randomly selected group of 1036 women with a vaginal delivery were analysed. Quality 
indicator frequency and adherence were scored in 2060 women with a CS or vaginal delivery.
Results
The expert panel developed 16 indicators on planned CS and 11 indicators on unplanned CS. 
Indicator adherence was calculated, defined as the number of women in a specific obstetrical 
situation in which care was performed as recommended in both planned and unplanned CS 
settings. The most frequently occurring obstetrical situations with low indicator adherence 
were: 1) suspected fetal distress (frequency 17%, adherence 46%), 2) non-progressive 
labour (frequency 12%, CS performed too early in over 75%), 3) continuous support during 
labour (frequency 88%, adherence 37%) and 4) previous CS (frequency 12%), with adequate 
counselling in 15%. 
Conclusions
We identified four concrete target groups for improvement of obstetrical care, which can be 
used as a starting point to reduce CS rates worldwide.
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Introduction 
There is a worldwide rise in caesarean section (CS) rates. Although the Netherlands has a 
relatively low CS rate (16.7%) compared to the United Kingdom (24.6%) and United States 
(32%), the most impressive rise in CS rate is found in ‘low risk pregnancies’: healthy women with 
a singleton in cephalic position at term [1, 2, 3, 4]. The World Health Organization estimates 
a CS rate between 10-15% to be optimal [5]. Although a CS is a relatively safe procedure, it 
is associated with increased short term morbidity and mortality, with an increased risk of 
abnormal placentation and uterine rupture in future pregnancies [6, 7]. Furthermore, rising 
CS rates are not associated with improved outcome for mother and neonate [8, 9, 10]. A CS 
costs twice as much as a vaginal delivery, (1256 euro to 9652 euro extra depending on the 
country of origin [11]. Adding all costs of future morbidity and increased risk of future repeat 
CS, the estimated additional costs of one CS are 7500 euro. 
The cause of the increasing CS rate is still unknown. Previous studies mostly focus on 
epidemiological data such as rising maternal age, maternal request for CS and decline in 
attempt of vaginal birth after CS [12, 13]. Applying the Robson Ten Group Classification 
system, others mainly identified the nulliparous single cephalic term pregnancy, as well 
as the women with a previous CS to be important contributors to the total CS rate [14, 
15, 16]. This neither reflects appropriate obstetrical care, nor shows which women need 
improvement of care. Our hypothesis is, that incomplete adherence to guidelines regarding 
the decision when to perform a CS might be an important explanation for the rising CS rate. 
This hypothesis is supported by hospital-level variation in CS rates, which cannot be explained 
by socio-demographic or clinical factors [12].
In recent decades, several international obstetrical organizations have developed evidence-
based guidelines with recommendations for optimal care regarding the decision when to 
perform a CS. However, the crucial issue remains whether these recommendations are 
actually followed. In order to improve current CS care, it is of importance to gain insight into 
the extent of guideline implementation in daily practice. Before this can be measured, valid 
quality indicators for optimal care have to be systematically developed [17, 18].
In the present study, we apply a systematic method for development of evidence-based 
obstetrical quality indicators. Based on these indicators, we compare current Dutch care 
to optimal care as described in international evidence-based guidelines. This will allow the 
identification of target groups of women in which a tailor-made implementation strategy 
might improve care and reduce CS rates. 
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Methods 
Development of CS quality indicators
A systematic RAND-modified Delphi method was used to select a set of key recommendations 
appropriate for transcription into quality indicators [18]. These recommendations were 
extracted from national guidelines (NVOG: Dutch Society of Obstetricians and Gynaecologists, 
CBO: Centraal Begeleidings Orgaan, a Dutch organization aiming at improving the quality of care 
by health care professionals), international guidelines (RCOG: Royal College of Obstetricians 
and Gynaecologists, ACOG: American Congress of Obstetricians and Gynaecologists, and 
SOGC: Society of Obstetricians and Gynaecologists of Canada) and literature [19, 20]. The 
national expert panel consisted of both obstetricians (N=13) and midwives (N=4) and were 
members of either the Dutch Society of Obstetrics and Gynaecology (NVOG) or the Royal 
Dutch Organization of Midwives (KNOV). The experts rated and discussed indicators on 
planned CS (including mode of delivery counselling and CS prevention) as well as indicators 
on unplanned CS ( in an iterative way. The exact procedure for indicator development is 
described in S1: Description of stepwise procedure of CS quality indicator development. 
Measurement of CS current care
Design and Setting
We conducted a retrospective multi-center cohort study. This study was situated within the 
Dutch Obstetric Consortium, which is a research collaboration of obstetric clinics in The 
Netherlands (http://www.studies-obsgyn.nl).
Study population 
In order to obtain a representative view of current CS care, this study was conducted in 21 
hospitals: 5 university hospitals, 10 non-university teaching hospitals and 6 non-university, 
non-teaching hospitals located in different regions of The Netherlands. To gain real insight 
in current obstetrical care and measure quality indicator adherence, women with a CS and 
women with a vaginal delivery (VD) were included. For example, consider the situation of 
breech presentation. In such a situation, an external cephalic version should be offered. In 
order to study guideline adherence, all women with a fetus in breech presentation after 34 
weeks need to be identified. In this case, adequate care is offering external cephalic version 
to women with a breech presentation after 34 weeks, independent of their acceptance or 
the result of the attempt.
Per hospital, the medical charts of 50 consecutive women who underwent a caesarean 
delivery as well as a random selection of 50 women who underwent a VD in the same 
period were analysed. Since it was inefficient to include and analyse all women with a VD, 
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a randomization list was developed per hospital based on the local CS rate. For example, if 
the CS rate was 20%, VD sampling rate was 0.25 (0.25*80%=20%). We excluded cases with 
major fetal abnormalities (defined as ‘abnormalities that interfere with standard obstetrical 
care or vaginal birth’), birth prior to 24 weeks of gestation and fetal demise prior to onset of 
delivery. Since the Medical Ethical Committee (CMO) of Maastricht (azM/UM) declared that 
no ethical approval was necessary for this study protocol, no informed consent was required. 
The patient data were anonymized.
Data collection
Trained research nurses from the Dutch Obstetric Consortium gathered the data. We 
extracted basic obstetrical data for all women from their individual medical charts; including 
data on previous deliveries (previous VD, CS) and current pregnancy (parity, singleton/ 
multiple gestation). Furthermore, we gathered indicator specific data for all women to enable 
calculation of adherence to each indicator. These data included conditions that might influence 
mode of delivery and existed prior to delivery (diabetes, hypertension) or developed either 
during pregnancy (suspected fetal macrosomia, intrauterine growth restriction) or during 
delivery (suspected fetal distress, non-progressive labour). Indicator specific data included 
ultrasound results, mode of delivery counselling, delivery specifics (e.g. use of ST-analysis 
or fetal scalp blood sampling, pain medication and oxytocin). We assessed indicator specific 
data for all women in order to evaluate whether care was provided according to guidelines.
Sample size
We assumed a mean adherence to the guidelines of 75%, an alpha of 0.05, and a precision 
of the estimation of 5%. Next, we assumed an intra-cluster correlation (ICC) of 0.2 and 80 
professionals in 20 hospitals. Taking clustering of data across clinicians and within obstetrical 
departments into account, 960 medical charts were needed for analyses. In order to 
compensate for loss to follow-up or incomplete data, at least 1,000 women with a CS needed 
to be included.
In order to enable the calculation of specific events (frequencies) as described in 
‘measurement of CS quality indicators’, a random selection of 1000 women with a vaginal 
delivery were included. This resulted in the analysis of 50 women with a VD and 50 women 
with a CS per hospital. 
Statistical analysis
To assess guideline adherence, performance scores per indicator were calculated, ranging 
from 0 to 100%. This was done as follows: the number of women to whom the indicator 
applied and actual care was consistent with the indicator (numerator) was divided by the 
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total number of women to whom the indicator applied (denominator). When an indicator was 
composed of aggregated items (e.g. the indicator ‘request for CS without medical grounds’), 
we calculated additional sub percentages for each item. In this case, sub percentages were 
calculated for 3 additional items: 1. explore reason for CS request, 2. discuss (dis)advantages 
to CS delivery and 3. offer psychological counselling in case of fear of delivery. Analyses were 
performed using SPSS statistics 21. 
Percentages were weighted for the hospital-specific sampling fractions used in sampling 
VDs. For example, if a sampling fraction of 0.25 was used in a particular hospital, data for 
each VD from that hospital counted four (1/0.25) times in the calculation of numerators and 
denominators. 
Results
Development of CS quality indicators 
Based on 51 recommendations, extracted from the guidelines, the stepwise procedure 
of indicator development (figure 1) resulted in a set of 27 CS quality indicators, including 
14 indicators on planned CS (mode of delivery counselling (CS versus VD) 13 indicators on 
prevention of CS. The procedure of CS quality indicator development is given in the appendix 
of this article. 
The final indicator set is given in Table 1. The indicators on planned CS are shown separately 
in Table S1 (Quality indicators on planned CS) in the appendix of this article.
Study population 
All 21 hospitals were asked to provide data of 50 VD as well as 50 CS, which would result in a 
study population of 2100 women. There were 22 women who met the exclusion criteria. Not 
every hospital analysed the requested 100 women, resulting in an analysis of 2060 women. 
When adjusting for the random selection of vaginal deliveries, these 2060 women represent 
a total study population of 4687 women.
Measurement of current care
Table 2 shows the frequency of specific obstetrical events, as described by the indicators, 
as well as the performance scores (indicating adequate care) in the total study population 
(N=4687 women) concerning: planned CS and unplanned CS. 
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STEP 1. Selection of the recommendations from the (inter)national guidelines and literature
STEP 2. Questionnaire round: prioritization on criteria health gain and overall efficiency 
STEP 3. Consensus meeting
STEP 4. Critical evaluation, operationalization and final approval
51 recommendations
National 
guidelines 20
Recommendations high 
potential 15
International 
guidelines 18
Recommendations uncertain 
potential 18
Literature 2
Additional 
recommendations 5
International + 
national guidelines 5
56 recommendations
27 recommendations
14 indicators on mode of 
delivery counseling
13 indicators on 
prevention of CS
Fig. 1. Stepwise procedure of CS quality indicator development
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Table 1. Set of CS quality indicators
1) Quality indicators on planned CS
A) General counseling, CS is not mentioned (VD is the normal conduct)
1. Twin pregnancy and first child cephalic position
2. Fetal macrosomia (<4.5kg in maternal diabetes, <5kg no maternal diabetes)
3. Preterm labor, cephalic position
4. Small for gestational age without fetal distress
5. Previous shoulder dystocia without impaired perinatal outcome 
B) Counselling directed at VD (VD and CS are options, VD is preferred)
6. Position of the placenta at 1-2cm of the internal os
Request for CS without medical grounds:
7. Explore reason for request
8. Discuss (dis)advantages to CS delivery
9. In case of extreme fear: offer psychological counselling
10. Preterm breech delivery (frank, complete breech)
C) Counselling mentioning both VD and CS as equal options
11. Breech presentation at term
Previous CS (Inform on risks and chance for successful VBAC)
12. Inform on low risk of uterine rupture
Table 1 continued.
1) Quality indicators on planned CS
C)   Counseling mentioning both VD and CS as aqual options
13. Inform on high chance of successful VBAC
14. Inform on increased risk and lower success rate in case of need for labor induction
D) Prevention of planned CS
15. Offer external cephalic version in case of non-cephalic position
16. Use of internal audit on CS
2) Quality indicators on unplanned CS
17. In case of suspected fetal distress use STAN (ST analysis) or micro blood analysis 
In case of non-progressive labor first stage:
18. Rupture of membranes,
19. Urinary catheterization,
20. Use of pain medication, preferably epidural analgesia,
21. Adequate contractions or augmentation of labor
In case of non-progressive labor second stage in nulliparous women:
22. Active pushing recommended,
23. Adequate contractions recommended,
24. Consider vacuum extraction if the head is <1/5th palpable per abdomen
25. Continuous support during labor for women with or without prior training
26. Use of partogram 
27. Involvement of consultant obstetrician in decision making for CS
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Table 2. Quality of care measured by CS quality indicator
1) Quality indicators on planned CS Frequency of 
occurrence
Performance score 
(adherence)
A) General counseling, CS is not mentioned (VD is the normal conduct)
Twin pregnancy and first child cephalic position 1.3% 16%
Fetal macrosomia (<4.5kg in maternal diabetes, <5kg no maternal diabetes) 4.3% 33%
Preterm labour, cephalic position 4.7% 45%
Small for gestational age without fetal distress 3.3% 43%
Previous shoulder dystocia without impaired perinatal outcome 1.1% 22%
B) Counseling directed at VD (VD and CS are options, VD is preferred)
Position of the placenta at 1-2cm of the internal os 0.02% 100%
Request for CS without medical grounds: 1%
• Explore reason for request 80%
• Discuss (dis)advantages to CS delivery 66%
• In case of extreme fear: offer psychological counseling 62%
Preterm breech delivery (frank, complete breech) 1.7% 1.3%
C) Counseling mentioning both VD and CS as equal options
Breech presentation at term 4.1% 56%
Previous CS (Inform on risks and chance for successful VBAC): 11.7% 4%
Previous CS and medical reason for induction of labour (inform on risks and chance 
for successful VBAC)
2.2% 18%
D) Prevention of planned CS
Offer external cephalic version in case of non-cephalic position 6% 77%
Table 2 continued.
2) Quality indicators on unplanned CS Frequency of 
occurrence
Performance score 
(adherence)
In case of suspected fetal distress use STAN (ST analysis) or micro blood analysis 16.9% 46%
In case of non-progressive labor first stage: 11.1%
• Rupture of membranes 95%
• Urinary catheterization 61%
• Use of pain medication 78%
• Use of pain medication: epidural analgesia 49%
• Adequate contractions recommended 93%
• Before performing a CS, an optimal situation (A-E)>2hrs 23%
• Before performing a CS, an optimal situation (A-E)>4hrs 15%
In case of non-progressive labor second stage in nulliparous women: 12.7%
• Active pushing recommended, 98%
• Adequate contractions recommended, 72%
• Consider vacuum extraction if the head is < 1/5th palpable per abdomen 45%
Continuous support during labor for women with or without prior training 88.3% 37%
Use of partogram 6.9% 54%
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1 Planned caesarean section
Table 2 shows that for planned CS, the frequency of the occurrence of the specific events 
ranged from 0.02% to 11.7% and adequate care (performance scores) ranged from 4 to 100%. 
Although in many obstetric situations caregivers do not follow guidelines, the impact on total 
caesarean section rate is not likely to change since the frequency of the situation is very 
low. This is the case for twin pregnancies with the first fetus in cephalic position, preterm 
breech and previous shoulder dystocia, occurring in less than 2% in the general population. 
The population with a high incidence and a low performance are women with a previous CS. 
In an average obstetric population, 11.7% of all women have a previous CS and in only 15% 
counselling regarding estimated success rates of a VD, next to risks and benefits involved 
with CS and VD according to the guidelines was documented. In addition, in only 4% of the 
medical charts of these women, comments informing on risks and benefits were detailed. 
The highest performance scores for this group of women were found for mode of delivery 
counselling in case of placenta position at 1-2cm of the internal os (100%), to offer external 
cephalic version for non-cephalic position (77%) and counselling on CS without medical 
grounds (62-80%). 
2 Unplanned caesarean section
Unlike the indicators for planned caesarean sections, the indicators for unplanned caesarean 
sections have a much higher frequency of occurrence, ranging from 11 to 88.3%. In these 
indicators, guideline adherence in general is higher ranging from 23 to 98%. 
Continuous support during labor was advised for all women starting vaginal birth. In 37% 
of these women the support was actually provided. It was advised to apply additional 
diagnostics such as ST-analysis or fetal scalp blood sampling to all women with suspected fetal 
distress, if this was technically possible and no contraindications existed to the procedure. In 
46% of the women with suspected fetal distress, additional diagnostics were applied before 
proceeding to a CS. In women with non-progressive labour, the performance scores of the 
separate quality indicators (artificial rupture of membranes, urinary catheterization, use of 
pain medication (preferably epidural analgesia and adequate contractions), ranged from 61% 
to 95%. However, the expert panel advised to proceed to a CS based on non-progression, not 
earlier than 2- 4 hours after all previous measures were fulfilled. Only in a small proportion of 
women, these criteria were met and in more than 77% CS were performed too soon. 
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Discussion
Main findings
This study resulted in a set of 27 evidence-based quality indicators on both planned as 
well as unplanned CS. Current care measurement in the Netherlands identified four major 
target groups for future implementation strategies due to their high prevalence and low 
adherence rate: improvement of counselling in women with a previous CS, improvement 
of implementation of continuous support during labour, additional diagnostics before 
proceeding to a CS in case of suspected fetal distress and allowing a longer waiting period 
before proceeding to a CS in case of non-progressive labour. 
Strengths and limitations 
Our study offers the first set of CS indicators covering entire obstetrical care, thereby enabling 
measurement of quality of obstetrical care in situations that exist antepartum (e.g. breech 
presentation), intrapartum (e.g. non-progressive labour) as well as postpartum (e.g. internal 
audit on CS). This is in contrast to previously developed indicators which only focussed on 
peripartum care [21]. We included 21 different types of hospitals in several regions in The 
Netherlands, analysing more than 1000 women per group in order to determine actual care. 
When comparing the data from our trial to data from the Foundation Perinatal Registration 
The Netherlands (PRN: the national obstetrical database), we find that the SC rate is 
comparable (22.2% versus 23.4%). With a similar distribution among planned and unplanned 
CS: 11.4%, 10.8% versus 10.5%, 12.9%, respectively [22]. Thus, we expect our results to be a 
good representation of actual care in The Netherlands.
 
Although a standardised method for the development of quality indicators was used, there 
are several limitations to this study. To date no study compared the different methods used 
for quality indicator development. However, the RAND-modified Delphi method offers a 
systematic approach to indicator development and is a frequently used method that has 
proven to result in valid quality indicators [23]. In addition, one can challenge whether all 
quality indicators are usable and accepted in different and specific international obstetrical 
settings. However, the obstetrical situations described (previous CS, non-progressing labor, 
suspected fetal distress) are comparable world-wide and the basis of the quality indicators 
consists of recommendations derived from international guidelines and literature [15, 24]. 
Although there may be a different approach in obstetrical care in some cases (e.g. preterm 
breech delivery, fetal blood sampling), we expect a similar approach by most obstetrical 
healthcare professionals to the identified major categories. Therefore, we believe that the 
most important quality indicators are likely to be adopted by most obstetrical healthcare 
professionals internationally. 
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The data collection from medical charts was performed by trained research nurses from 
the Dutch consortium, which could introduce bias. It was shown by Luck et al. that medical 
chart review somewhat underestimates the actual care given [25]. Not every detail of a 
consultation is noted in the medical chart. Secondly, despite the fact that trained research 
employees extracted the data, there might be interpretation bias. However, when considering 
the adherence percentages for the main categories (fetal distress, non-progressive labour 
and previous CS) in our study, we do not expect our results to change substantially. 
Interpretation
In case of a rare situation like triplets, discussing the necessity of CS will only lead to marginal 
improvement of general care. However, an improvement strategy will have a considerably 
larger effect in case of a situation with a relatively high frequency and low adherence rate, 
such as non-progressive labour. The CS quality indicators allowed us to analyse obstetrical 
care in the Netherlands, thereby identifying groups of women in whom a high frequency 
of a certain quality indicator is observed in combination with low adherence. The next step 
in improvement of care will be to determine factors that influence the mode of delivery 
decision, by either facilitating or hindering quality indicator adherence. Based on these 
influencing factors, a tailor-made implementation strategy is expected to have a high impact 
on obstetrical care. It is essential to evaluate the effect of such a strategy on actual obstetrical 
care in terms of indicator adherence, CS rate, as well as maternal and neonatal outcome.
An analysis of data from the Consortium on Safe Labor by Boyle et al. showed that the most 
common indications for a primary CS in their US population were failure to progress (35.4%) 
and non-reassuring fetal rate tracing (27.3%) [24]. Furthermore, using the same data, Zhang 
et al found that the a repeat CS rate was a major contributor to the total CS rate (30.9%) 
[15]. The target groups we identified are commonly mentioned indications for a CS globally, 
implying that our results are comparable to international data. Ample attention is paid to 
interventions that might increase trial of labour as well as vaginal birth after caesarean 
section [26, 27]. There is increasing interest in the prevention of the primary CS, which 
means CS indications for the nulliparous single cephalic at term are an important factor: 
non-progressive labor and suspected fetal distress [24, 28, 29, 30]. Therefore, intervention 
in these groups are likely to have a high impact on current care internationally. The impact of 
an implementation strategy might vary internationally, depending on local CS rate, size of the 
target group and local barriers to optimal care. Countries with a high rate of elective repeat 
CS might benefit more from the same implementation strategy compared to countries with a 
relatively low CS rate. Not all interventions are applicable internationally. 
In the United States for example, ST-analysis and fetal blood sampling are not practiced. 
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However, these measures are indicators for good care in our study, and an uptake of these 
interventions might optimize care.
 
In general, the cost of a CS is about double that of a vaginal delivery [11]. After a first CS, 
a large majority of women have a CS in the subsequent pregnancy, ranging from 18 to 
72% depending on the country women live in [31]. For each repeated CS, the morbidity 
increases, with higher risks of operative complications, blood transfusions, IC admittance 
and hysterectomy, adding  extra costs [6-10]. Therefore, with on average one subsequent 
pregnancy, the extra costs are estimated to approach 7500 Euro. In Europe, 5.2 million women 
delivered in 2012, with on average a 30% CS rate. With a reduction of 1%, in Europe alone 
390 million Euro can be saved. The WHO advocates a CS rate between 10-15%, although this 
has been challenged. This would result in a cost reduction of 3.9 billion euro every year, with 
no likely harmful effect on maternal or neonatal outcomes.
Beside the use of the presented indicators for local improvement, a subset could be used for 
international comparison of CS care. Until now, interhospital and international comparison 
was directed at classification of CS rates, but this does not reflect quality of care [14, 15, 16, 
32]. We believe that comparison of CS care could be directed at the subset of indicators that 
have the highest impact: 1) in women with a previous CS, structured information on risks and 
benefits on vaginal delivery compared to planned CS should be given and women should be 
given a choice; 2) women should be offered continuous support during vaginal delivery 3) 
before performing a CS for suspected fetal distress, fetal blood sampling or ST-analysis should 
be performed; 4) before performing a CS for non-progressive labour, a 2-4 hour waiting 
period should be installed after a situation with ruptured membranes, adequate contractions 
and adequate pain relief is established. Prior to applying this on an international basis, local 
current care should be established, as well as local facilitating and hindering factors. 
Conclusions
This study provides a framework for future studies for improvement of guideline adherence 
and reduction of CS rates, thereby possibly improving the outcome for mother and child. 
Due to the relatively high frequency of occurrence in combination with a low adherence 
rate, we identified possible target groups where a tailor-made implementation strategy could 
improve CS care: offer continuous support during labour, women with a previous CS and 
women undergoing their primary CS for non-progressive labour or suspected fetal distress. 
The next step will be to identify barriers and facilitators that influence guideline adherence 
and incorporate them in an implementation strategy to improve care. 
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Appendix - Stepwise procedure of CS quality indicator development
Methods           
The method of indicator development was carried out according to four consecutive steps: 
1) identification of recommendations, 2) questionnaire round, 3) consensus meeting and 4) 
critical evaluation and operationalization. 
Step 1: Identification of recommendations
Five international guidelines were used to extract recommendations: guidelines of the 
ACOG (n=1), RCOG (n=3) and SOGC (n=1). In addition, all national guidelines of the Dutch 
Society of Obstetricians and Gynaecologists (NVOG) with recommendations that may 
affect CS rates were used (e.g. fetal surveillance during labor, breech presentation, twin 
pregnancy etc.). Furthermore, the guideline on antiretroviral therapy by the CBO (Centraal 
BegeleidingsOrgaan), a Dutch organization aiming at improving the quality of care by health 
care professionals, was selected. In addition, the articles of Silverberg et al. and Robson et al. 
were used for their information on condyloma treatment in pregnancy and medical audit to 
reduce CS rates, respectively.[14, 15] 
Subsequently, the recommendations were categorised as follows: 1) planned CS (including 
recommendations on counselling on vaginal delivery (VD) versus caesarean section (CS) in 
different situations and prevention of planned CS) 2) unplanned CS. The recommendations 
considering counselling include situations in which a) general counselling is advised without 
mentioning the possibility of choosing CS (VD is the normal conduct); b) counselling is 
advised directed at VD (VD and CS are both options but VD is preferable; c) counselling is 
advised mentioning both VD and CS as equal options; and d) planned CS is advised. 
Step 2: Questionnaire round
The identified recommendations were subdivided according to the abovementioned 
categories and were transformed into a questionnaire that was sent to the expert panel. If 
available, the questionnaire contained the evidence level per recommendation in order to 
support the decision-making process. The experts were asked to rate each recommendation 
on a nine-point Likert scale with respect to their value for both health gain and overall efficacy. 
In order to be able to distinguish between recommendations with a high score on the Likert 
scale, a ranking of recommendations per category was used. Furthermore, the experts were 
requested to add complementary recommendations. This part of the procedure resulted in 
an allocation of the recommendations for the consensus meeting into recommendations 
with high, uncertain or low potential as quality indicator. 
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Recommendations were considered ‘high potential’ if: 1) the median rating of the 
recommendation was 8 or more; 2) the recommendation was in the top ranking of the 
specific category and had at least 20% of the maximum score and 3) 70% or more of the 
expert panel ratings were in the highest tertile on the Likert scale (7, 8 or 9). There were three 
possible appraisal combinations that rated the recommendation as ‘uncertain potential’: 1) 
a median score of 8 or more and a top ranking for less than 20% of the maximum score; 2) a 
median score less than 8 and a ranking for at least 20% of the maximum score or 3) a rating 
of 30% or more in the highest (7, 8 or 9) and lowest tertile (1, 2 or 3) on the Likert scale 
(=disagreement). The recommendation was determined to have ‘low potential’ if none of the 
abovementioned criteria were applicable.[16]
Step 3: Consensus meeting 
In a face-to-face consensus meeting the results of the questionnaire round were discussed. 
In order to improve the debate each expert was provided with the overall results from the 
questionnaire round, as well as their own ratings and additional remarks. Firstly, the experts 
were asked if they agreed that the recommendations marked ‘high potential’ indeed had 
to be selected as potential quality indicators to assess and monitor quality of care, and 
whether or not they could agree to the dismissal of those recommendations considered ‘low 
potential’ as quality indicators. In addition, the experts were requested if there were any 
recommendations marked as ‘uncertain potential’ they would strongly advise to consider 
as an indicator. The members of the expert panel were finally asked which additional 
recommendations proposed by an expert would be suitable as quality indicator.
Step 4: Critical evaluation and operationalization
After the consensus meeting the results were offered to all the members of the expert panel 
for final approval. Subsequently, the selected recommendations were translated into indicators 
by defining numerators and denominators, i.e. the number of women in whom a certain test or 
intervention should have been performed and has been performed, divided by the number of 
women in whom a certain test or intervention should have been performed. Using this method, 
an adherence percentage could be calculated in order to assess current care. 
Results
Step 1: Identification of recommendations
In the first step, 51 recommendations on CS were identified: 16 situations where VD was 
the preferred mode of delivery (category 1a and 1b); 9 situations in which counselling was 
advised on the possibility of choosing either vaginal or caesarean delivery (category 1c); 
2 recommendations on prevention of planned CS (category 1d), and 14 situations where 
planned CS was advised. Furthermore, there were 8 recommendations on unplanned CS. 
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Step 2: Questionnaire round
The 17 experts each received a questionnaire, of which 16 were returned (2 non-responders, 
94% response rate). Out of the 51 recommendations, 14 had ‘high potential’, 18 had ‘uncertain 
potential’ and 19 had ‘low potential’. The experts suggested 5 additional recommendations. 
Step 3: Consensus meeting
Eight experts attended the consensus meeting (47%), 5 obstetricians and 3 midwives. This 
meeting resulted in a consensus-based set of 27 key recommendations labelled according to 
two categories [See Table 1]. Category 1 comprised 14 recommendations on mode of delivery 
counselling: 1a) general counselling is advised without mentioning the possibility of choosing 
CS (VD is the normal conduct) (N=5); 1b) counselling is advised directed at VD (VD and CS 
are both options but VD is preferable) (N=5), 1c) counselling is advised mentioning both VD 
and CS as equal options (N=4). There were 2 recommendations on prevention of planned 
CS (1d). The experts approved of 11 recommendations on the prevention of unplanned CS 
(category 2).
With regard to the situations were planned CS was advised (category 1d), the 12 indications 
were not considered to be of high potential for measuring quality of care. For example, in case 
of placenta praevia, it is not likely that an obstetrician would proceed with VD. Consequently, 
it is not expected that adherence to such an indicator would be low, and improvement of 
care would be necessary. 
Step 4: Critical evaluation, operationalization and final approval
The 27 key recommendations were sent to the expert panel for final approval, which was 
obtained from 16 experts; there was 1 non-responder. Finally, the selected recommendations 
were translated into indicators by defining numerators and denominators: i.e. the number of 
women in whom a certain intervention or counselling method should have been performed 
and has been performed, divided by the number of women in whom a certain intervention 
or counselling method should have been performed. 
For example: one of the indicators states that in case of breech presentation after 34 weeks, 
external cephalic version should be offered. Guideline adherence then is measured by 
dividing the number of women in the study group with a fetus in breech presentation after 
34 weeks in whom external cephalic version is offered by the total number of women with a 
fetus in breech presentation after 34 weeks. 
This stepwise procedure resulted in a set of 27 CS quality indicators, including 16 indicators on 
planned CS as well as 11 indicators on unplanned CS (Table S1). The process of development 
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of quality indicators on CS by using the RAND-modified Delphi method is depicted in Figure 
1, the final indicator set is given in Table 2. 
Table S1. Quality indicators on planned CS
Planned CS is advised: 
Suspected placental abruption and viable fetus
Vasa praevia 
Placenta praevia 
Placenta localization less than 1cm from the internal os
Relevant scar in the uterus (e.g. vertical incision during previous CS)
Monoamniotic twin pregnancy
Breech presentation at term and maternal pelvic abnormality
Breech presentation at term and previous non-progressive labor 
First genital herpes outbreak in the third trimester of pregnancy
Impossible vaginal birth (e.g. due to cervical myomas, congenital malformations)
Uterine rupture in previous pregnancy
Persistent transverse presentation, despite external cephalic version
 53
3
CS QUALITY INDICATOR DEVELOPMENT AND MEASUREMENT

Identification of barriers and 
facilitators for optimal 
cesarean section care: 
perspective of professionals 
Sonja Melman, Rachel Hellen Petra Schreurs, Carmen Desiree Dirksen, Anneke Kwee, Jan 
G Nijhuis, Nicol Anna Cornelia Smeets, Hubertina Catharina Johanna Scheepers, Rosella 
Petronella Maria Gemma Hermens. 
BMC Pregnancy Childbirth 2017;17:230.
4
Abstract
Introduction
The cesarean section (CS) rate has increased over recent decades with poor guideline 
adherence as a possible cause. The objective of this study was to explore barriers and 
facilitators for delivering optimal care as described in clinical practice guidelines. 
Material and methods
Key recommendations from evidence-based guidelines were used as a base to explore 
barriers and facilitators for delivering optimal CS care in The Netherlands. Both focus group 
and telephone interviews among 29 different obstetrical professionals were performed. 
Transcripts from the interviews were analysed. Barriers and facilitators were identified and 
categorised in six domains according to the framework developed by Grol: the guideline 
recommendations (I), the professional (II), the patient (III), the social context (IV), the 
organizational context (V) and the financial/legislation context (VI). 
Results
Most barriers were found in the professional and organizational domain. Barriers mentioned 
by healthcare professionals were disagreement with specific guideline recommendations 
and hesitation to allow women to be part of the decision making process. Other barriers are 
lack of adequately trained personal staff, lack of collaboration between professionals and 
lack of technical equipment. 
Conclusions
Clear facilitators and barriers for guideline adherence were identified in all domains. Several 
barriers may be addressed by using decision aids on mode of delivery or prediction models to 
individualise care in women in whom both planned vaginal delivery and CS are equal options. 
In women with an intended vaginal delivery, adequate staffing and the availability of both 
fetal blood sampling and epidural analgesia are important. 
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Introduction 
The cesarean section (CS) rate has increased over recent decades in both developed and 
developing countries. The World Health Organization has targeted the CS rate to be 10% to 
15%, although this low rate has recently been questioned (1,2). In The Netherlands, the CS 
rate has increased steadily over the past decade from 10.8% in 1999 to 16.5% in 2014 (3,4). 
In absolute numbers, the most impressive rise was documented among healthy women with 
a singleton in vertex position between 37 and 42 weeks gestation (5). Furthermore, in The 
Netherlands in 2013, a large variation in vaginal delivery rates per hospital were observed in 
the nulliparous term singleton vertex group, with rates ranging from 45.1-73.2% (6).
This worldwide increasing CS rate is cause for concern since this will lead to increased 
maternal and neonatal complications, increased risks for future pregnancies, and increased 
healthcare costs (7-10). Literature mainly focusses on individual-level explanations for the CS 
rise, including increased maternal age, technological innovation, women’s choice or clinical 
risk factors such as obesity and previous CS. However, these explanations do not account for 
the majority of the variation observed (11). 
In order to optimize CS practice, the Royal College of Obstetricians and Gynecologists 
developed an evidence-based guideline with clear recommendations that have a direct 
effect on the decision to perform a CS (12). In the caesarean section implementation study 
(SIMPLE), a RAND-modified Delphi procedure resulted in 27 quality indicators describing 
optimal CS care based on international guidelines and literature (13). The adherence to CS 
quality indicators was measured in 21 hospitals in The Netherlands in order to gain insight 
into current obstetrical care.
Besides insight into optimal and current care, insight into facilitators and barriers among 
all professionals involved in CS decision-making is essential. This insight can support 
the development of a tailored strategy to overcome barriers and improve guideline 
implementation. The present qualitative study explored facilitators and barriers for optimal 
CS care among midwives, obstetrical residents and obstetricians. 
Material and methods
Design
A qualitative study was conducted in 2011 to determine facilitators and barriers that influence 
the decision to perform a CS from a healthcare professionals’ perspective. Two separate 
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focus group interviews were performed; one with obstetricians and one with obstetrical 
residents from different regions and different types of hospitals in The Netherlands. Due to 
organizational difficulties a focus group among independent midwives could not be arranged. 
Therefore, we conducted telephone interviews among nine midwives until data saturation 
was reached (the last interview did not reveal any new information). 
Setting
Currently in The Netherlands, pregnant women without medical complications are supervised 
by a registered midwife (primary care) and have the possibility to choose where to give birth 
(at home or in an outpatient hospital setting). If medical complications exist or develop during 
pregnancy or delivery, the attending midwife refers the pregnant woman to an obstetrician 
in a hospital (secondary care). Certain obstetric situations may lead to an advise to deliver 
by planned CS, whereas others may lead to the need for counselling on risks and benefits of 
a planned vaginal delivery opposed to a planned CS. Mode of delivery counselling is mostly 
performed by obstetricians and residents. Therefore, all situations that may lead to a planned 
CS are the responsibility of secondary care. However, referring midwifes may provide their 
opinion before referral and are often consulted by the women for second opinion and are 
therefore an influencing factor.
 
Study population
Thirty obstetricians and residents from university and non-university hospitals in different 
regions of The Netherlands were invited to participate to focus group interviews. The 
obstetricians and residents were all members of the Dutch Society of Obstetrics and 
Gynaecology. The midwives were invited based on recommendations from the Dutch 
National Association of Midwifery and worked in primary or secondary care.
The Medical Ethical Committee (CMO) of Maastricht (azM/UM) declared that no ethical 
approval was necessary for this study protocol (09-4-047), since it is not considered a study 
according to the Medical Research Involving Human Subjects Act (WMO: Wet medisch-
wetenschappelijk onderzoek met mensen). 
Development interview guide and data collection
Quality indicators from the SIMPLE study (based on key recommendations on CS care, 
abstracted from guidelines of the Royal College of Obstetricians and Gynaecologists, the 
American Congress of Obstetricians and Gynecologists, the Dutch Society of Obstetrics 
and Gynaecology and the Society of Obstetricians and Gynaecologists of Canada) were 
used as a base for exploration of barriers and facilitators (Table S1, appendix) (13). These 
quality indicators considered mode of delivery counselling, planned CS and prevention 
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of (emergency) CS, and were discussed separately during the interviews. Facilitators and 
barriers were explored at different domains, based on the model developed by Grol (14-15) 
concerning the guideline recommendations itself (domain I), the professional (domain II), 
the patient (domain III), the social domain (domain IV), the organizational domain (domain 
V) and the financial/legislation domain (domain VI). The focus group interview among 
obstetricians was moderated by a project member (obstetrician). The focus group interview 
among residents was moderated by another project member (resident). Individual telephone 
interviews among midwives were conducted by the same resident.
Statistical analysis
The interviews were fully transcribed and analysed using the qualitative analysis tool of 
ATLAS.ti GmbH Version 7 (Berlin, Germany). Two reviewers (SM and RS) independently read 
the interviews and coded facilitators and barriers for each of the recommendations and 
transcripts. The identified factors were assigned to the appropriate domains. Disagreements 
were resolved by discussion between the reviewers. If there was no consensus, a third 
independent reviewer was consulted (RH). 
Results
The obstetricians worked at non-university non-teaching hospitals (N=6) or non-university 
teaching hospitals (N=4). Five residents from a non-university hospital, and five residents 
from a university hospital were included. The midwives worked either in a private practice 
(N=5) (rural and urban areas), non-university hospital (N=3) or university hospital (N=2). 
A total of 38 barriers and 11 facilitators were identified (Table S2, appendix), which mainly 
concerned the professional and organizational domain, described in detail hereinafter.
Domain I: The CS guideline recommendations
All types of professionals mentioned that guidelines do not adequately consider individual 
patient characteristics that might influence guideline adherence. As one of the obstetricians 
described: 
‘If the woman is a nullipara, pregnant with a child that is expected to be large 
for gestational age and with a fetal head not engaged at term, it depends on her 
characteristics whether or not I will discuss a CS’.
This barrier mainly applies to guidelines aiming at vaginal birth in specific situations, such 
as fetal macrosomia, labour dystocia, breech presentation and previous shoulder dystocia. 
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Furthermore, obstetricians mentioned that guidelines were not easily available on the 
professional website, whereas residents noted that local protocols were not always recently 
updated.
Furthermore, not all professionals agreed with guideline recommendations. Almost all types 
of professionals disagreed with the recommendation: ‘A CS should not be mentioned in case 
of a previously experienced shoulder dystocia if there is no residual neonatal damage’. The 
decision to offer a CS mainly depends on the severity of the previous shoulder dystocia, and 
not on residual neonatal damage alone.
Domain II: The professional domain
Obstetricians and residents mentioned unclear documentation on previous deliveries, 
including advice on mode of delivery in future pregnancies, as an important barrier for 
guideline adherence. Furthermore, they stated that incomplete counselling or unclear 
documentation of the decision making process for mode of delivery in the current pregnancy, 
is an important factor for acting in line with the agreed mode of delivery. For example:
You have planned a CS for a woman with a history of fetal macrosomia (4500 grams) 
and shoulder dystocia. If labour starts prematurely, you might advise her to undergo 
a vaginal delivery, since the expected fetal weight is probably less than 4000 grams’.
Lack of experience regarding clinical skills in daily practice was also mentioned among all 
types of professionals to affect guideline adherence, mainly concerning vaginal breech 
deliveries, fetal scalp blood sampling and external cephalic version. The mode of delivery will 
largely depend on the attending obstetrician. 
Another barrier mentioned by the residents regarding the use of fetal scalp blood sampling 
is the large variation in policy between obstetricians as well as between hospitals. Some 
obstetricians favour a vacuum extraction when full dilatation of the cervix is reached, 
whereas others would prepare for fetal scalp blood sampling in order to, possibly, avoid 
operational vaginal delivery. 
Obstetricians mentioned that the ability to assess the cardiotocogram remotely as facilitator 
for optimal care, since this improves communication between the obstetrician on call and 
the resident without the necessity to be present at the delivery ward.
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Domain III: The patient context
A barrier mentioned by obstetricians and residents is mode of delivery advice by friends or 
family of a pregnant woman. Particularly negative experiences regarding the outcome of the 
neonate are perceived to be cause of anxiety and reduced cooperation of a pregnant woman, 
which can complicate communication between a pregnant woman and her caregiver. 
Another barrier mentioned by obstetricians is that they feel it might be difficult for women 
to adequately balance current and future fetal risks, next to maternal risks and benefits in 
choosing mode of delivery. 
‘Counselling in pregnancy is fundamentally different, since it concerns the mother but 
also her child. Women seem more concerned for their current child than for a possible 
future pregnancy. Sometimes weighing the risks of a vaginal birth after previous CS, 
also considering future pregnancies, is even difficult for healthcare providers’.
Domain IV: The social context
All types of professionals mentioned troublesome collaboration as a barrier. Some residents 
might hesitate to call the anaesthesiologist, especially at night. As one of the residents 
described:
‘In our hospital, the residents are not allowed to independently consult the 
anaesthesiologist at night. We first have to call the obstetrician, and he or she has to 
consult the anaesthesiologist. It is a barrier for providing epidural anaesthesia at night.’
Clear agreements on availability of epidural analgesia are mentioned to be a facilitator in this 
situation. 
The residents and midwives mentioned the presence of a strict hierarchy and wide variation 
in obstetrical policy between obstetricians as barriers for collaboration. The hierarchy causes 
some residents and midwives to be reluctant in providing feedback on a decision. An open 
attitude is essential in an obstetrical team. Residents add that the decision to perform a CS 
for non-progressing labour might also depend on the time (evening or night). 
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Domain V: The organizational context 
Some barriers are specifically related to the Dutch obstetrical care system. All types of 
professionals mentioned there are no general agreements on the responsibility for mode of 
delivery counselling. Some obstetricians feel they should be responsible for mode of delivery 
counselling. One of the midwives described: 
`Obstetricians are sometimes even angry that we already performed the mode of 
delivery counselling and that the pregnant woman chose her mode of delivery.’
In women with a previous CS, obstetricians and residents stated that, although a consultation 
in secondary care is preferred before 20 weeks of pregnancy, the current habit of referral to 
secondary care at 36 weeks of pregnancy seems too late for an adequate shared decision 
making process on mode of delivery. Women are often already fully focussed on a particular 
mode of delivery, which makes counselling by an obstetrician more difficult. Protocols for 
cooperation between first and secondary care, considering mode of delivery counselling, as 
well as timing of referral, would facilitate optimal care. 
Considering the use of additional diagnostics for evaluating the fetal condition during labour, 
prior to performing a CS for suspected fetal distress, there are several barriers perceived 
by residents and midwives. Fetal scalp blood sampling might be limited due to technical 
limitations during sample collection or sample assessment in laboratories. The procedure 
seems time consuming and often needs to be repeated. One of the residents adds:
`At first, we had to send the collected blood samples to the laboratory. After they 
bought a new device, approximately 3 out of 4 samples could not be analysed. You do 
not wish to experience that.’
Domain VI: The financial/ legislation domain
Finally, it was mentioned by all professionals that there is insufficient staffing and monetary 
compensation in order to provide continuous support for women during labour. 
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Discussion
Main findings
In order to improve CS care, a high level of adherence to evidence based clinical guidelines 
is required. We conducted a qualitative study to determine which factors influence the 
adherence to recommendations that have a direct effect on the decision to perform a CS. 
Among professionals, we identified 11 main facilitators and 38 main barriers for optimal care 
to previously developed quality indicators on mode of delivery counselling, planned CS and 
prevention of CS (13). 
In our study on actual care, the groups of women with highest expected impact on 
improvement of care concerned women with a previous CS, and nulliparous women in 
whom continuous support was not always given, in whom an unplanned CS is performed 
for suspected fetal distress without applying additional diagnostics (ST-analysis or fetal scalp 
blood sampling), or in whom an unplanned CS is performed for non-progressing labour 
without adequate waiting period (2-4 hours). 
Regarding counselling women with a previous CS, professionals hesitate to allow women 
to be part of the decision making process, since they fear women are not equipped to 
decide on mode of delivery when balancing risks and benefits for both their own health, 
that of their baby and a possible future pregnancy. A main facilitator for obstetricians and 
residents was detailed mode of delivery counselling and clear documentation of the decision 
making process for mode of delivery, emphasizing the importance of adequately describing 
the counselling process and also to discuss exceptions or conditions to the agreed mode of 
delivery. Structured counselling using decision aids can help to address women’s anxiety and 
when the content of this counselling is agreed upon by both first and second line healthcare 
providers, variation in care between different healthcare providers is likely to reduce. Using 
prediction models may help to individualise care.
Regarding unplanned CS in nulliparous women, the Dutch ministry of Health supports 
continuous support during labour, although this is not guaranteed in every day practice. 
Furthermore, 24/7 availability of epidural analgesia is agreed upon, however this is not 
always implemented. The remarks stating that timing of a CS is partially based on the time of 
day suggests that availability of different healthcare providers is a clear barriere.
Interpretation
The present study is, to our knowledge, the first to analyse facilitators and barriers for optimal 
CS care with international guidelines as a basis. Chaillet et al. studied the implementation of 
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guidelines on vaginal birth after CS in Quebec, Canada. They concluded that adoption of 
guidelines may be improved if local healthcare professionals’ perceptions are considered 
(16). In line with our study, others identified availability of equipment and staff, skill levels, 
acceptance of guidelines and women’s motivations to be of influence (16,17).       
               
There are however, some factors that can be explained by cultural differences or local habits, 
for example economical, political or medico-legal concerns. In the study by Chaillet et al., 
obstetricians mentioned medico-legal concerns on several occasions as a barrier for optimal 
care (16). This is not in line with our findings, probably due to differences in medico-legal 
habits. The study of Yazdizadeh et al., revealed several barriers regarding the economic and 
political domain, which may be explained by a differently regulated healthcare system in Iran 
(17). 
The unique structure of the Dutch obstetrical care system entails several challenges for health 
care providers in terms of continuity of care, referral of pregnant women and responsibility 
of care. When considering the Dutch healthcare system, improved collaboration between 
midwives and obstetricians seems an important step in improvement of care. 
Strengths and limitations
As framework for the interviews, we used recommendations derived from evidence based 
guidelines on CS care, as described in the SIMPLE study (13). Barriers and facilitators were 
explored for those factors that are considered as most important for measuring optimal CS 
care.   
         
We invited different types of obstetric healthcare providers that might have an influence 
on the offered CS care to participate to this qualitative study: obstetricians, residents and 
midwives, respectively. Professionals from different types of hospitals and private practices 
from different Dutch regions participated to this study, thereby representing all different 
elements of Dutch obstetrical care. The different types of healthcare providers were 
interviewed separately, in order to let them speak without restraint. The main barriers and 
facilitators were frequently mentioned among all different types of professionals, suggesting 
that the identified barriers are useful for the development of a new implementation strategy.
Although a standardized method for the identification of barriers and facilitators was 
used, there are some limitations to this study. First, the analysis of the interviews is prone 
to interpretation bias. In order to reduce this bias, all interviews were interpreted by two 
independent reviewers, based on the theoretical model by Grol (14,15). 
64 
4
CHAPTER 4
Since the influencing factors were identified using a qualitative, explorative method, no 
quantitative conclusions can be justified by this method. Finally, this study is performed in 
a national setting. The interviews were based on previously developed quality indicators, 
derived from national and international guidelines. We identified some facilitators and 
barriers that are typical for the Dutch system, concerning the collaboration between first 
and secondary care: for example the responsibility for mode of delivery counselling and 
barriers relating to the timing of referral from midwife to obstetrician. It is, however, in line 
with literature that there are barriers specific to regional habits and practice (16,17). With 
international guidelines as a basis, we consider most results to be potentially relevant for 
international use, since our results describe the availability of equipment and staff, acceptance 
of guidelines and women’s motivations to be of influence in line with literature. 
              
Conclusion
In conclusion, clear facilitators as well as barriers for guideline adherence were identified at all 
domains, yet particularly on professional and organizational domain. During implementation 
of CS guidelines, professionals should be aware of the identified barriers and facilitators and 
take these into account. 
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Appendix
Table S1. Set of CS quality indicators 
1) Quality indicators on planned CS 
A) General counseling, CS is not mentioned (VD is the normal conduct)
1. Twin pregnancy and first child cephalic position
2. Fetal macrosomia (<4.5kg in maternal diabetes, <5kg no maternal diabetes)
3. Preterm labor, cephalic position
4. Small for gestational age without fetal distress
5. Previous shoulder dystocia without impaired perinatal outcome 
B) Counselling directed at VD (VD and CS are options, VD is preferred)
6. Position of the placenta at 1-2cm of the internal os
Request for CS without medical grounds:
7. Explore reason for request
8. Discuss (dis)advantages to CS delivery
9. In case of extreme fear: offer psychological counselling
10. Preterm breech delivery (frank, complete breech)
C) Counselling mentioning both VD and CS as equal options
11. Breech presentation at term
Previous CS (Inform on risks and chance for successful VBAC)
12. Inform on low risk of uterine rupture
13. Inform on high chance of successful VBAC
14. Inform on increased risk and lower success rate in case of need for labor induction
D) Prevention of planned CS
15. Offer external cephalic version in case of non-cephalic position
16. Use of internal audit on CS
2) Quality indicators on unplanned CS
17. In case of suspected fetal distress use STAN (ST analysis) or micro blood analysis 
In case of non-progressive labor first stage:
18. Rupture of membranes,
19. Urinary catheterization,
20. Use of pain medication, preferably epidural analgesia,
21. Adequate contractions or augmentation of labor
In case of non-progressive labor second stage in nulliparous women:
22. Active pushing recommended,
23. Adequate contractions recommended,
24. Consider vacuum extraction if the head is <1/5th palpable per abdomen
25. Continuous support during labor for women with or without prior training
26. Use of partogram 
27. Involvement of consultant obstetrician in decision making for CS
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Changing the evaluation of 
caesarean section care: 
combining the Robson Ten-Group 
Classification System with 
valid quality indicators.
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Commentary
The discussion on optimal CS rates is on-going. Although the World Health Organization 
(WHO) recommended an ideal caesarean section rate between 10% and 15%, caesarean 
section rates of up to 19% are associated with lower maternal or neonatal mortality rates 
[1,2]. The Euro-Peristat study revealed wide variation in CS rates, ranging from 14.8% in 
Iceland to 52% in Cyprus with no relation to neonatal outcome [3]. The Netherlands has a 
relatively low CS rate (17%), but detailed analysis of guideline adherence showed room for 
improvement in many cases [4]. Even in a country with a “close to ideal rate”, the rise in CS 
rates in ‘low risk pregnancies’ (healthy women with a singleton in cephalic position at term 
with an intended vaginal delivery) is remarkable [5]. The SIMPLE study showed that in these 
women emergency CS rates ranged from 2.5 to 12.3%, which could largely be explained by 
patient characteristics. 
In 2015, the WHO further recommended the use of the Robson Ten-Group Classification 
System (RTGCS) in order to categorise women in ten mutually exclusive obstetrical subgroups 
[1,6]. The international use of this system is advised in order to be able to compare CS 
rates between countries and hospitals and to allow an insight into changes in CS rates over 
time. Based on a systematic review, Torloni et al. concluded that the RTGCS was the most 
optimal classification system [7], yet this system makes no distinction between planned and 
unplanned CS. Moreover, it categorises women with induction of labour into the same group 
as women with planned CS [8]. 
The most important purpose of such a classification system would be the improvement 
of obstetrical care and preventing unwanted CS. However, simply comparing CS rates per 
hospital or country does not reflect appropriate use of a CS. In order to prevent unnecessary 
CS and improve care, it is essential to take the next step. We studied the Robson classification 
in the Netherlands, and the major contributors to the CS rate are not very different from 
other countries [9,10]: nulliparous women with a singleton in cephalic position after 37 
weeks in spontaneous labor (17.1%) (group 1), nulliparous women with a singleton in 
cephalic position after 37 weeks induced or CS before labor (14.2%) (group 2), and women 
with a previous CS (23.8%) (group 5) (unpublished sub analysis of SIMPLE I data: available in 
the appendix). Therefore, even in a low CS rate setting as the Netherlands, the groups that 
mainly contribute to the CS rate remain identical. This supports the idea that improvement 
of care needs more than mere classification. In the SIMPLE study we developed 27 valid 
evidence based quality indicators, extracted from international guidelines, and measured 
these in actual care [4]. We identified groups that contribute mostly to the CS rates, in whom 
guidelines are frequently not adequately followed and, therefore, in which improvement of 
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care is most likely to be effective. 
In order to add more content to international comparison of CS rates, we suggest combining 
the major contributors to the CS rate based on the RTGCS with our quality indicators focused 
on content, particularly: 
1) The percentage of women with a singleton in cephalic position after 37 weeks with one 
prior CS who are adequately counseled on the risks and benefits of intended vaginal 
birth after CS and are given a choice.
2) The percentage of nulliparous women with a singleton in cephalic position after 37 
weeks who deliver by unplanned CS due to non-progressing labor in absence of signs 
of fetal distress, in whom the following actions are executed before a CS is performed: 
a) Amniotomy, adequate pain relief and adequate oxytocin augmentation for at least 
4 hours.
b) Active pushing at full dilation, and, if no contraindications exists, vaginal instrumental 
delivery is offered. 
These indicators could serve both in a prospective registration and could also be used in an 
audit and feedback of CS cases [11].
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Appendix
Introduction
The Robson Ten-Group Classification System was developed in 2001 in order to describe 
subgroups of women who experience different CS rates (Table 1) [6].
Table 1. Ten-group Classification System according to Robson
RTGCS Groups
1. Nulliparous, single cephalic, >37 weeks, in spontaneous labour
2. Nulliparous, single cephalic, >37 weeks, induced or CS before labour
3. Multiparous (excluding previous CS), single cephalic, >37 weeks, in spontaneous labour
4. Multiparous (excluding previous CS), single cephalic, >37 weeks, induced or CS before labour
5. Previous CS, single cephalic, >37 weeks
6. All nulliparous breeches
7. All multiparous breeches (including previous CS)
8. All multiple pregnancies (including previous CS)
9. All abnormal lies (including previous CS)
10. All single cephalic, < 36 weeks, (including previous CS)
These ten groups are mutually exclusive, totally inclusive and prospectively identifiable. This 
classification system provides the opportunity to compare CS rates among subpopulations 
between institutions, as well as over time in the same institution [7]. Since 2001, several 
modifications have been proposed in order to optimize this system [8,12,13]. There are also 
new insights on the appropriate use of the RTGCS [14,15]. The RTGCS allows epidemiological 
comparison of CS care. However, this classification system does not provide insight into 
indications for a CS, or the actual care provided. 
Another method of comparison and measurement of actual obstetric care in order to reduce 
CS rates is described in the SIMPLE study (caesarean Section IMPLEmentation) [4]. The 
RAND-modified Delphi method was applied to develop quality indicators on CS care. Next, 
these quality indicators were used to measure actual CS care, which allows the identification 
of groups of women where improvement of care might be possible. 
Four possible target groups of women were identified; 1) suspected fetal distress during 
labour, 2) non-progressive labour, 3) continuous support during labour and 4) previous CS .
A ten group analysis was performed to examine the obstetric outcome in women who 
delivered in 21 different hospitals in The Netherlands (SIMPLE study population), in order to 
gain insight into the CS rate per risk group. 
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Results
The results of the ten group analysis are given in table 2. 
Table 2: Robson Ten-Group Classification  RTGCS group
Total 
deliveries 
N (%)
CS 
deliveries 
total N
CS rate 
per group 
%
Planned CS  
per group 
N (%)
Emergency 
CS per 
group N (%)
Contribution 
to CS rate %
 1. Nulliparous, single cephalic, >37 
weeks, in spontaneous labour
1395 (31.1) 171 12.3 - 171 (12.3) 17.2
 2.  Nulliparous, single cephalic, >37 
weeks, induced or CS before 
labour
593 (13.2) 140 23.6 26 (4.4) 114 (19.2) 14.1
 3. Multiparous (excluding previous 
CS), single cephalic, >37 weeks, 
in spontaneous labour
812 (18.1) 27 3.3 - 27 (3.3) 2.7
 4. Multiparous (excluding previous 
CS), single cephalic, >37 weeks, 
induced or CS before labour
506 (11.3) 63 12.4 40 (7.9) 23 (4.5) 6.3
 5. Previous CS, single cephalic, >37 
weeks
478 (10.7) 237 49.6 155 (32.4) 82 (17.2) 23.8
 6. All nulliparous breeches 163 (3.6) 128 78.5 113 (69.3) 15 (9.2) 12.9
 7. All multiparous breeches 
(including previous CS)
92 (2.1) 69 75 61 (66.3) 8 (8.7) 6.9
 8. All multiple pregnancies 
(including previous CS)
85 (1.9) 33 38.8 20 (23.5) 13 (15.3) 3.3
 9. All abnormal lies (including 
previous CS) 
29 (0.6) 29 100 25 (86.2) 4 (13.8) 2.9
 10 All single cephalic, <36 weeks, 
(including previous CS)
328 (7.3) 97 29.6 71 (21.7) 26 (7.9) 9.8
  Total 4481 (100) 994 - 511 483 100
The CS rate in this population is 22%, with 11% planned CS and 11% emergency CS. Women 
in groups 1 to 4 represent relatively uncomplicated pregnancies. There are 3306 women 
classified (73.8%) in these four groups, with a contribution to the total CS rate of 40.3%. 
Group 1 (nulliparous women, single cephalic, full-term pregnancies in spontaneous labour), 
is the largest group in our selected population, representing 31% of the women (N=1395). In 
this group of uncomplicated pregnancies 171 women delivered by CS (12.3%), with a relative 
contribution to the total CS rate of 17.2%. 
Of the 593 women in group 2 (nulliparous, single cephalic, full term, induced or CS before 
labour) 23.6% delivered by CS. Induction of labour contributed more to the CS rate in this 
group then planned CS: 19.2% emergency CS rate versus 4.4% planned CS rate, respectively. 
The contribution of group 2 to the total CS rate is 14.1%.
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The CS rate in group 3 (multiparous, no previous CS, single cephalic, > 37 weeks, in 
spontaneous labour), however, is the lowest of the groups described to be uncomplicated 
pregnancies, with a CS rate of 3.3% and a contribution to the total CS rate of 2.7%. 
In group 4 (multiparous, no previous CS, single cephalic, > 37 weeks, induced or CS before 
labour) 12.4% of the 506 women delivered by CS, with a relative contribution to the total CS 
rate of 6.3%. 
The largest contributor to the total CS rate in our population is group 5 (multiparous women, 
single cephalic, full-term pregnancies with a previous uterine scar). Fifty percent of the 478 
women in this group delivered by CS, representing a contribution of 23.8% to the total CS rate. 
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Abstract
Objective
To externally validate two models from the United States (entry-to-care (ETC) and close-to-
delivery (CTD)) that predict successful intended vaginal birth after caesarean (VBAC) for the 
Dutch population. 
Design and setting
A nationwide registration-based cohort study. Seventeen hospitals in the Netherlands.
Population
Seven hundred and sixty-three pregnant women, each with one previous caesarean section 
(CS) and a viable singleton cephalic pregnancy without a contraindication for an intended 
VBAC.
Methods
The ETC model comprises the variables maternal age, pre-pregnancy body mass index (BMI), 
ethnicity, prior vaginal delivery, prior VBAC and prior nonprogressive labour. The CTD model 
replaces pre-pregnancy BMI with third-trimester BMI and adds estimated gestational age at 
delivery, hypertensive disease of pregnancy, cervical examination and induction of labour. 
We included consecutive medical records of eligible women who delivered in 2010. For 
validation, individual probabilities of women who had an intended VBAC were calculated.
Main outcome measures
Discriminative performance was assessed with the area under the curve (AUC) of the receiver 
operating characteristic and predictive performance was assessed with calibration plots and 
the Hosmer–Lemeshow (H-L) statistic.
Results
Five hundred and fifteen (67%) of the 763 women had an intended VBAC; 72% of these (371) 
had an actual VBAC. The AUCs of the ETC and CTD models were 68% (95% CI 63–72%) and 
72% (95% CI 67–76%), respectively. The H-L statistic showed a P-value of 0.167 for the ETC 
model and P = 0.356 for the CTD model, indicating no lack of fit. 
Conclusion
External validation of two predictive models developed in the United States revealed an 
adequate performance within the Dutch population.
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Introduction
After a first caesarean section (CS), a pregnant woman can opt for an elective repeat CS 
(ERCS) or an intended vaginal birth after caesarean (VBAC) (i.e. a trial of labour), which will 
result in an actual (successful) VBAC or an emergency CS (unsuccessful VBAC). Discussing 
the risks of both options is a substantial part of counselling on mode of delivery, and 
obviously the probability of having an actual VBAC is a key component [1,2]. Published 
success rates for VBAC worldwide vary between 60 and 80% [3]. However, these rates 
are not necessarily applicable for counselling, since individual probabilities may vary due 
to factors relating to demography, obstetric history and current pregnancy of the woman 
[3,4]. Hence, a personalised prediction of VBAC may lead to a more refined counselling. 
Furthermore, with regard to clinical outcomes, personalised prediction could contribute to 
risk estimation because actual incidences of major maternal morbidity are lowest in women 
who have a VBAC (0.2%), followed by women having an ERCS (0.8%), and are highest in 
women having unsuccessful VBAC (3.8%) [5]. In addition, several studies have shown that 
low probabilities of successful VBAC are related to relatively high risks of major feto-maternal 
morbidity [6,7]. Several scoring models that aim for a personalised prediction of successful 
intended VBAC have been published [3,8]. In this work, the predictive models of Grobman 
et al. are evaluated [9,10]. These models can be used early in pregnancy [9] and at the onset 
of labour [10] in order to estimate the probability of successful intended VBAC during an at 
term delivery. Both models have previously been successfully validated in an independent 
cohort in the United States and were called the ‘entry-to-care model’ (ETC) and the ‘close-to-
delivery model’ (CTD) [11,12]. Additionally, the ETC model has been successfully validated for 
a Japanese population [13]. However, differences in, for example, population characteristics 
and setting may affect the validity of the predictive models in European countries like the 
Netherlands. For instance, in the United States, the VBAC rate when the predictive models 
were derived was 12–22% [14]; this declined to approximately 8.3% in 2007 [15]. In most 
European countries reported VBAC rates are higher, for example 54% in the Netherlands [16] 
and 30–37% in the United Kingdom [2,17]. Hence, in this study we aim to externally validate 
the prediction models of Grobman et al. for the Dutch population [9,10].
Methods
Setting
This nationwide registration-based cohort study was performed in 17 hospitals in the 
Netherlands, with a good representation of all geographic regions and hospital types. 
Hospitals types included university teaching hospitals (n=5), nonuniversity teaching hospitals 
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(n=7) and nonuniversity nonteaching hospitals (n=5). Approval for this study was obtained at 
the Medical Ethical Committee (CMO) of Maastricht University Medical Centre+ (MUMC+) 
(MEC number 09-4-047-13).
Population
The two predictive models were designed for women who have a vertex singleton pregnancy 
and a history of one low-transverse CS and who delivered at term (gestational age ≥37 
weeks), therefore only women who met these criteria were included in the present study. 
As in the studies of Grobman et al. [9,10], women with an unknown indication for previous 
CS, an antepartum intrauterine fetal demise or a contraindication for vaginal delivery were 
excluded. Contraindications for vaginal delivery were defined as placenta praevia and a 
uterine scar with extension into the fundus. 
Since we expected a large difference between the VBAC rate in the United States and the 
current VBAC rate in the Netherlands, we collected data from women who had an intended 
VBAC and from women who had an ERCS. The main consideration was to estimate the current 
VBAC rate in the Netherlands and subsequently to fully evaluate the applicability of the 
models in the Dutch population by comparing the baseline characteristics of the intended 
VBAC group and the ERCS group. 
Sample size
The sample size was calculated according to the ‘rule of thumb’ of at least ten events per 
variable in the predictive model [18]. An event was defined as an unsuccessful intended VBAC. 
Based on previously published data, it was assumed that the percentage of unsuccessful 
intended VBACs in the Netherlands would be 24% [16]. As the predictive models contained 
as many as 12 variables per model, the calculated minimum sample size was 500 subjects 
(12 × 10/0.24).
Data collection
At all participating sites, data were extracted from consecutive birth records according to a 
standardized operating procedure by using customized case report forms. Information was 
obtained on all predictive indicators included in the predictive models. Data were obtained 
by trained research nurses, medical doctors or senior medical students. In order to achieve 
the required sample size, each participating hospital was asked to include 30 consecutive 
cases of intended VBAC and all ERCSs in the same time interval, starting from 1 January 2010. 
Variables
Variables were defined as described in the original articles of Grobman et al. [9,10].The 
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outcome variable used for validating the predictive models was the outcome of the intended 
VBAC, i.e. either successful intended VBAC (vaginal birth) or unsuccessful intended VBAC 
(emergency CS). 
To be able to incorporate all variables despite the different units and definitions used in the 
two countries, some of the collected data had to be converted or redefined. All decisions 
on the conversion and redefinition of variables were approved by both a Dutch and an 
American obstetrician (HS and WG). The variables that had to be adapted were ‘ethnicity’ 
(in the United States the categories were African-American/Hispanic/White and others), 
‘fetal station’ and ‘cervical effacement’. In the Netherlands seven categories of ethnicity are 
used (Dutch, other European, Mediterranean, African, Indo-surinamese, Asian and ‘other’). 
To correspond to the categories in the original prediction models, the variable ‘African-
American’ was set equal to the Dutch variable ‘African’. The variable ‘Hispanic’, did not match 
any of the Dutch categories and was therefore abolished. Subsequently, the variable ‘White 
and others’ comprised all Dutch ethnicity categories except for ‘African’. The variable ‘fetal 
station’ was collected according to the ‘Hodge classification system’, which ranges from 
Hodge 0 (H0) to Hodge 4 (H4). Fetal station was converted into the American classification 
system, which ranges from ballottable (B) to +5. It was redefined as follows: H0=–5; H1=–3; 
H2=–1; H3=0; H4=+3. The variable ‘cervical effacement’ was collected in three categories, 
namely (1) ≤25%, (2) 25–50% and (3) ≥50%, as these are the categories in which these data 
are registered in the Netherlands. For analysis we set category 1 equal to 20%, category 2 
equal to 40% and category 3 equal to 75%. Furthermore, the variable ‘third trimester body 
mass index (BMI)’ was approximated by adding 15 kg to ‘pre-pregnancy weight’; this was 
considered appropriate for the Dutch population based on expert opinion.
Data quality and missing data
Data were entered and checked for inconsistencies. Inconsistent and incomplete data 
were double-checked directly with the hospital concerned. As shown in Table 5.1, for most 
variables there was only a small quantity of missing data. However, pre-pregnancy BMI 
was missing in 24% of women. A multiple imputation strategy was used for data analysis, 
since complete case analysis alone can result in a large loss of power and might yield biased 
parameter estimates.
Data analysis
Study cohort characteristics
Characteristics of the women who had an ERCS and women who had an intended VBAC 
were compared. To compare proportions, the chi-squared test, or when appropriate Fisher’s 
exact test, was used. For continuous variables, an independent sample t test was used for all 
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samples as data were normally distributed. A P-value < 0.05 was used to indicate statistical 
significance. 
Predicted probabilities
To validate the prediction models, for each patient who had an intended VBAC an individual 
probability of achieving VBAC was calculated with the following prediction equations 
obtained from the research articles of Grobman et al. [9,10]:
1. The ETC model [9]:
exp(w)/[1 + exp(w)]
where
w=3.766–0.039 (age, years)–0.060 (pre-pregnancy BMI)–0.671 (African-American 
ethnicity)–0.680 (Hispanic ethnicity)+0.888 (previous vaginal delivery)+1.003 (vaginal 
delivery after previous CS)–0.632 (previous CS due to nonprogressive labour).
2. The CTD model [10]:
exp(w)/[1 + exp(w)]
where
w=7.059–0.037 (age, years)–0.044 (third-trimester BMI)–0.460 (African-American 
ethnicity)–0.761 (Hispanic ethnicity)+0.955 (previous vaginal delivery)+0.851 (vaginal 
delivery after previous CS)–0.655(previous CS due to nonprogressive labour)-0.109 
(estimated gestational age at delivery)–0.499 (hypertensive disease of pregnancy) 
+0.044 (cervical effacement, deciles)+0.109 (cervical dilation, 0–6 cm)+0.082 (fetal 
station, B to +5, entered as 0 to 11)–0.452(labour induction).
Additionally, using the ETC model we calculated the mean predicted probability of achieving 
VBAC for women in the ERCS group and compared it with the mean predicted probability 
in the intended VBAC group. The purpose of this comparison was to evaluate whether the 
variables of the predictive models are already being taken into account during counselling. 
As data were not normally distributed, the mean predicted probabilities of achieving VBAC 
were compared using a Mann–Whitney U test. We only performed this analysis with the ETC 
model because the CTD model includes intrapartum factors and was therefore not applicable 
to the ERCS group. 
Discriminative and predictive performance
The discriminative performance of the predictive models was assessed using a receiver 
operating characteristic (ROC). The ROC was obtained by plotting sensitivity against 1-specificity. 
Sensitivity was defined as the fraction of VBACs that were correctly predicted for a particular 
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cut-off point, whereas specificity was defined as the fraction of unsuccessful intended VBACs 
that were correctly predicted. The ability of the models to discriminate between women with 
a high and low probability of achieving a VBAC was assessed using the area under the curve 
(AUC) of the ROC. The AUC can vary between 0.5 and 1.0, in which a value of 0.5 represents 
no discriminative capacity and 1.0 represents excellent discriminative capacity.
The predictive performance of the models was assessed by a calibration curve. The calibration 
curve was computed to show the relation between predicted probability of achieving 
VBAC and the observed VBAC rate. To obtain these values, the predicted probability was 
categorized into quantiles. In each quantile, the mean predicted VBAC rate was calculated 
and plotted against the observed VBAC rate in the corresponding quantile. In addition, to 
assessing goodness-of-fit, we computed the Hosmer–Lemeshow (H-L) statistic. The H-L 
statistic measures the fit of the calibration curve with the assumption (null hypothesis) that 
observed and predicted values are equal. A P-value <0.05 was considered to show lack of fit 
of the tested prediction models. 
Distribution of probabilities
In order to determine the clinical utility of the models, we evaluated whether the model 
could classify a notable portion of women away from the VBAC population mean. Hence, 
we evaluated the distribution of probabilities amongst the cohort. The distributions were 
plotted in bar charts on the x-axis in the calibration plot. Additionally, we computed the 
percentage of the cohort that can be classified away from the VBAC population mean; we 
used cut-off values of 60% or less and 80% or higher. 
Software
Statistical analyses and plots were performed using SPSS (SPSS v. 18.0) software and R, a 
language and environment for statistical computing.
Results
Inclusions
We reviewed 9833 consecutive medical records of women who had delivered in the 
participating hospitals since January 2010. One thousand and sixty-eight women (11%) had a 
history of CS, 763 of whom (71%) met the inclusion criteria. Of these 763 women eligible for 
intended VBAC, 515 (67%) had an intended VBAC and 248 (33%) had an ERCS. Three hundred 
and seventy-one women (72%) delivered vaginally, resulting in an actual VBAC rate in our 
study cohort of 49% (371/763). 
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Study cohort characteristics
The population distributions with respect to the variables contained in the two predictive 
models are shown in Table 5.1. Women who had a previous vaginal delivery and/or a 
previous VBAC were more likely to attempt a VBAC. Women who had an intended VBAC also 
had a significantly lower BMI, although the actual difference between groups was small. On 
the other hand, women with a previous CS due to nonprogressive labour more often opted 
for ERCS. Women who had an ERCS delivered at a significantly lower gestational age. Based 
on the ETC model, women who chose a VBAC had a significantly higher mean predicted 
probability (P<0.00) of successful intended VBAC (72±14%) than women who chose an ERCS 
(64±14%).
Table 5.1 Baseline characteristics of study cohort of women with a previous caesarean section.
Variable Missing data intended 
VBAC /ERCD (n/n)
Intended VBAC
(n=515)
ERCS
(n=248)
P-value a
Maternal age (years, mean ± SD) 2/4 32 ± 5 33 ± 4 0.15
Ethnicity (n, (%))
 Dutch
 Mediterranean
 Other European
 African
 Indo-Surinamese
 Asian
 Other
15 /12 388 (75)
37 (7)
17 (3)
24 (5)
7 (1)
12 (2)
15 (3)
192 (77)
11 (5)
11 (4)
6 (3)
1 (0)
7 (3)
8 (3)
0.53
0.14
0.44
0.14
0.45
0.68
0.81
Pre-pregnancy BMI (kg/m², mean ± SD) 124/79 25 ± 6 27±7 <0.00
Previous CS due to failure to progress (n, (%)) 0/0 201(39) 135(54) <0.00
Any previous vaginal delivery (n, (%)) 0/0 127(25) 25(10) <0.00
Previous VBAC (n, (%)) 0/0 99(19) 8(3) <0.00
PE/HELLP (n, (%)) 0/2 9(2) 6(2) 0.58
Gestational age at delivery (days, mean ± SD) 0/0 279 ± 8 273 ± 9 <0.00
Cervical dilation (cm, mean± SD) 11/ b 3 ± 2 b b
Cervical effacement (%, (mean ± SD)) 56/ b 64 ± 19 b b
Fetal station (B, -5 - +5 , mean ± SD) 57/ b -2 ± 2 b b
Induction of labour (n, (%)) 0/ b 132(26) b b
a Results of χ²-tests/ Fisher’s exact test / t-tests; b Not applicable. SD: standard deviation, VBAC: vaginal birth after caesarean, 
ERCS: elective repeat caesarean section, CS: caesarean section, BMI: body mass index, PE: Preeclampsia HELLP syndrome: 
haemolysis, elevated liver-enzymes, low platelets, B: ballottement.
Discriminative performance
The discriminative performance of the predictive models is shown in Figure 5.1. The ROC of 
the ETC model has an AUC of 68% (95% CI 63–72%). The ROC of the CTD model has an AUC 
of 72% (95% CI 67–76%).
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Figure 5.1 ROC of the entry-to-care model (AUC 68%; 95% CI 63–72%) and the close-to delivery model (AUC 
72%; 95% CI 67–76%), indicating the discriminative performance of both models concerning the probability of 
a successful vaginal birth after CS.
Predictive performance
The overall calibration of both predictive models was good. The mean successful intended VBAC 
rate in this study cohort was 72%. The mean predicted probabilities for successful intended 
VBAC in the ETC and the CTD models were 72±14% and 70±16%, respectively. The predictive 
performances of the models are shown in the calibration curves in Figures 5.2 and 5.3. 
Both models show acceptable calibration; the calibration in the high-probability ranges was 
particularly good. The CTD shows better calibration than the ETC model. The H-L statistic 
showed a P-value of 0.17 for the ETC model and 0.36 for the CTD model, which indicates 
reasonable calibration of both predictive models.
Distribution of probabilities
The bar charts on the x-axes of Figures 5.2 and 5.3 show the distribution of probabilities of 
successful VBAC amongst the cohort. Figure 5.2 shows that when the ETC model is applied, 
the majority of the cohort has a predicted probability around or above the VBAC population 
mean of 60–80%. In our cohort, 27% had a predicted probability above the VBAC population 
mean as these women had a predicted probability of 80% or higher. Furthermore, 19% of 
the women had a predicted probability below 60%. As shown in Figure 5.3, with application 
of the CTD model the distribution of predicted probabilities is also concentrated around and 
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above the VBAC population mean. In total, 31% of women had a predicted probability above 
80%, and 26% had a predicted probability below 60%.
Figure 5.2 Calibration plot of the entry-to-care model with the observed frequency of a successful vaginal birth 
after caesarean section by the predicted probability. The triangles indicate quantiles of women with a similar 
predicted probability of success.
Figure 5.3 Calibration plot of the close-to-delivery model with the observed frequency of a successful vaginal 
birth after caesarean section by the predicted probability. The triangles indicate quantiles of women with a 
similar predicted probability of success. 
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Comment
Main findings
External validation of two predictive models developed in the United States revealed adequate 
performance of both models within the Dutch population. Although overall calibration was 
acceptable, it was particularly good in the range of high predicted probability of successful 
intended VBAC. Discriminative capacity was reasonable for both models. Most women had a 
score within the population mean of 60–80% [3], yet a notable minority was classified away 
from this population mean. Further, this study shows that in the Netherlands intended VBAC 
is still common practice, as shown by the intended VBAC rate of 67%. Our results also suggest 
that preselection already occurs to some extent without applying a model.
Interpretation
According to guidelines on prognostic research, even a predictive model that seems promising 
requires external validation in different populations and settings [19]. Ethnicity and the 
probability of attempting VBAC were the main observed differences between the Dutch and 
American settings, although other factors like intrapartum policy may also exist. We consider 
our results to be roughly generalizable to most other western European countries with 
comparable ethnicities and VBAC rates. External validation in our Dutch cohort showed some 
loss of discriminative performance, as the original AUCs were 75% (95% CI 74–77%) instead 
of 68% (95% CI 63–72%) for the ETC model and 77% (95% CI 76–78%) instead of and 72% 
(95% CI 67–76%) for the CTD model. As shown, this finding was more pronounced for the ETC 
model. These findings are consistent with the previous validation studies performed in an 
American cohort by Costantine et al. who used a validation method comparable to our study 
[11,12]. However, the results contrast with the findings in a Japanese cohort where an AUC of 
80% (95% CI 72–89%) was obtained [13]. However, because no information was provided in 
that article on variable conversion and there appeared to be an additional selection criterion 
regarding whether women were actually in labour, no actual comparison with our results 
could be made. 
A review by Kaimal et al. highlighted that most women would like to be involved in decision-
making about mode of birth [20]. Also, women expressed their wish for personalised 
information [20]. Hence, implementation of a predictive model could provide this tailored 
information by allowing estimation of the risk of emergency CS and the related risk of feto-
maternal morbidity [6,7]. 
The ideal predictive model would distinguish between a successful intended VBAC and a 
failed intended VBAC by polarising the cohort into two groups: women with a very high 
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predicted probability and women with a very low predicted probability of achieving a 
VBAC. In comparison with other models that predict successful VBAC, the performance 
of the ETC and CTD models is average to good [4,8]. However, for decision-making about 
mode of delivery after previous CS we consider it helpful to also distinguish women with a 
high or low probability of VBAC from those with an average probability. The ETC and CTD 
models show the potential to classify a notable portion of women away from the population 
mean, which might induce better a distribution with regard to risk classification of women 
amongst intended VBAC and ERCS. Therefore we think that a predictive model could not 
only contribute to more personalised counselling but also to a reduction in feto-maternal 
morbidity. However, the actual usefulness of such a model in terms of usability, applicability, 
change in birth preferences and feto-maternal morbidity should be further explored in a 
randomised controlled trial. 
Strengths and weaknesses
A strength of this study is that it was performed in a multicentre setting with a good 
representation of types of hospitals and geographic regions in the Netherlands, which 
increased the external validity of our results. Furthermore, our data collection provides 
insight into the current (intended) VBAC rates in the Netherlands and into the prognostic 
profiles of women who opt for an intended VBAC and ERCS. By performing classification 
analysis we are able to show the subgroup of women who will have a probability of VBAC that 
is different from current population means [1,2]. 
We also recognise some limitations to our study. Firstly, there was a possible loss of 
discriminative performance of the validated models due to the necessary redefinition 
and conversion of variables into Dutch units. We had to redefine fetal station from a scale 
consisting of 12 steps ranging from B to –5 to +5 to the Dutch scale that consists of five steps 
and ranges from 0 to 4. Redefinition could induce misclassification and loss of refinement 
within variables, and thereby compromise model performance. Furthermore, in both models 
ethnicity is an important predictor. Though ethnicity has been recognized as an important 
demographic factor with regard to the probability of successful VBAC,4 the underlying 
mechanism is unknown and might be influenced by socioeconomic factors. Therefore, the 
ethnicity categories might not be compatible in other settings. Hence, we recommend re-
estimation of ethnicity and the intrapartum variables before application of the models in 
an impact study or clinical practice. A second drawback is that we had to approximate the 
variable ‘third trimester BMI’ as it could not be obtained from the charts. This may have led 
to imprecision and impairment of the performance of the models. Thirdly, the models would 
ideally be evaluated through application in a prospective setting. Application of the models 
might induce different birth preferences in women, selecting women with more favourable 
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prognostic profiles for successful VBAC. This might alter model performance. Furthermore, a 
limitation with regard to the validated models that must be addressed concerns the timing of 
counselling. We consider that, from a medical point of view, counselling on mode of delivery 
should ideally occur in the third trimester of pregnancy, because then other factors can be 
incorporated that are known in late pregnancy such as estimated fetal weight (EFW) and 
whether labour needs to be induced. The ETC model does not take these factors into account 
whilst the CTD model is applicable when there is an indication for induction of labour or 
when labour has already started. In this regard, in terms of practical use, a predictive model 
that can be used in the third trimester would be more suitable for the Dutch setting. 
Conclusion
External validation of two predictive models developed in the United States revealed 
adequate performance of both models within the Dutch setting. The predictive models 
can classify a notable portion of women away from the VBAC population mean. However, 
whether women indeed perceive the information on probability of successful VBAC as useful 
and whether the models hold when applied in a prospective setting should be additionally 
evaluated. Additional redefinition of the ‘ethnicity’ variable for a western European setting 
and transformation of both models into one model for third-trimester counselling could 
enhance model performance and increase applicability to the Dutch setting.
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Summary and general discussion
7 
Summary and general discussion
This thesis focused on studies to improve caesarean section (CS) care. The main aim was to 
identify groups of women in whom care was frequently not according to evidence based 
guidelines and in whom improvement is likely to be (cost) effective and feasible. This 
was most likely the case in women with a frequently occurring clinical situation and low 
adherence to CS guideline recommendations. To do so, we firstly defined what optimal CS 
care was, measured current adherence to this optimal care and assessed which women 
were most likely to benefit from an improvement strategy. Subsequently, we studied what 
factors were hindering or helping professionals to provide optimal care and particularly 
which factors (medical and non-medical) influenced the unplanned (emergency) CS rate in 
nulliparous women. With these insights a strategy to improve CS care could be developed. 
In this chapter, the main findings are described and discussed. In addition, implications for 
clinical practice and future directions for research are given. 
Main findings
• Using the RAND-modified Delphi method, in total, 16 indicators on planned CS and 11 
indicators on unplanned (emergency) CS were developed. The indicators on planned CS 
mainly described clinical situations in which a planned CS is clearly the best option (e.g. 
placenta previa ), situations in which both a CS and a vaginal delivery are considered 
reasonable options (e.g. breech presentation), and situations in which a vaginal delivery 
is the generally accepted policy (e.g. single foetus in cephalic presentation). (Chapter 3)
• The most frequently occurring obstetrical situations with low indicator adherence were: 
1) women with a previous CS (frequency 12%), with adequate counselling in 15%, 2) 
suspected foetal distress (frequency 17%, adherence 46%), 3) failure to progress 
(frequency 12%, CS performed too soon in over 75%), and 4) continuous support during 
labour (frequency 88%, adherence 37%). (Chapter 3)
• Based on evidence based guidelines, barriers and facilitators were explored in all domains. 
Most barriers were found in the professional and organizational domain. Healthcare 
professionals mentioned disagreement with specific guideline recommendations and 
hesitation to allow women to be part of the decision making process as barriers. Also 
lack of adequately trained personal staff, lack of collaboration between professionals 
and lack of technical equipment were identified as barriers. (Chapter 4)
• Applying the Robson Ten Group Classification System showed that the major contributors 
to the CS rate in The Netherlands are not very different from other countries: nulliparous 
96 
7
CHAPTER 7
women with a singleton in cephalic position after 37 weeks in spontaneous labor 
(17.1%), nulliparous women with a singleton in cephalic position after 37 weeks induced 
or CS before labor (14.2%), and women with a previous CS (23.8%). We suggested to 
apply the SIMPLE quality indicators to the major contributors to the CS rate identified in 
a Robson Ten-Group analysis. This would allow a more detailed analyses of the CS rate 
and may identify points for improvement of CS care. (Chapter 5)
• Two prediction models for successful intended vaginal birth after caesarean section 
(VBAC) developed in the United States were evaluated: the entry to care (ETC) and 
close to delivery (CTS) model. External validation of these predictive models revealed an 
adequate performance in the Dutch population. Sixty-seven of the 763 women had an 
intended VBAC; 72% of these had an actual VBAC. The discriminative capacity of both 
the ETC and CTD model were reasonable: 68% (95% CI 63–72%) and 72% (95% CI 67–
76%), respectively. Analysis of predictive performance showed no lack of fit. (Chapter 6)
Discussion, implications for clinical practice and future 
directions
Women with a previous CS: optimal counselling
The largest group of women in whom a discussion on mode of delivery (CS or an intention of 
a vaginal delivery) is important, are women with a previous CS (11% in our study population). 
The Dutch guideline dating from before 2010 stated that women need to be informed on 
their options, the risk of a uterine rupture, as well as the chances of vaginal birth and the 
increased risk of uterine rupture in case of labour induction. It became clear that only a 
minority of women were actually counselled and that a majority of these women weren’t 
even offered an option at all [1]. Our study on the hindering factors showed a general 
reluctance of caregivers to discuss the options since they feared that women would opt for 
a planned CS and they believed that this would result in a significant rise in the CS rate. This 
was considered an unwanted effect [2]. A problem with counselling is that the chances of 
a vaginal birth as described in the guideline are 70-75% but it is also clear that this differs 
substantially between women. 
We validated two prediction models on successful intended vaginal delivery after prior CS 
and they proved to have adequate predictive performances [3]. The use of these models can 
differentiate risk profiles. 
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For example: a woman with a BMI of 38, a previous CS due to non-progressing labour and a 
large baby in the current pregnancy, suggesting the need for labour induction, has a chance 
of a vaginal delivery of about 32%. On the other hand, a woman with a BMI of 22, a previous 
CS due to breech presentation with a normally sized baby, and a spontaneous onset of labour 
has a chance of a vaginal delivery of about 79%. It is known that morbidity is lowest in 
women who actually deliver vaginally, but women with a planned CS have lower morbidity 
than those with an unplanned (emergency) CS. Therefore, the first woman in our example 
may indeed have lower morbidity when she does not choose to deliver vaginally. 
Besides medical risks and benefits, it is likely that women who are involved in their decision 
making will be more satisfied than those who feel that decisions have been made for them. 
In our (unpublished) data on women’s experiences the feeling not being involved was one of 
the main reported negative experiences in case of an unplanned CS. 
The question remains what the effects on involving women in the decision making will be. The 
use of decision aids has been demonstrated to be helpful and we suggest the development 
of a decision aid for this specific situation [4,5]. Since the chance of an actual successful 
vaginal delivery after a trial of labour is of the utmost importance for the estimation of risks 
and benefits, we suggest a prediction model for the Dutch population be developed. The 
existing models were developed in the United States, based on cohorts in which only a small 
minority of women actually opt for vaginal delivery [6,7]. Therefore, although these models 
perform adequately, a more specifically designed model may perform better. Furthermore, 
their models are set in early pregnancy and in early labour. In the Dutch situation, the 
discussion on mode of delivery usually takes place in the third trimester. 
Our hypothesis is that women can be involved in the decision making without a significant rise 
in the CS rate. We believe that a shift from unplanned to planned CS in case of a low chance 
of vaginal birth improves outcome and that the Dutch culture of wanting to deliver vaginally 
is strong and most women do not opt for a planned CS if their chances of delivering vaginally 
are high. This however, needs to be tested. And even if a rise in de CS rate is observed but 
women report higher involvement and satisfaction, it can be questioned what the definition 
of “good outcome” is.
Following the results of this study, a decision aid was developed according to the IDPASS 
criteria [8,9]. Furthermore, a prediction model including the following parameters was 
developed [10]: 
• reason for previous CS non progressing labour: yes/no
• BMI
98 
7
CHAPTER 7
• caucasian ethnicity: yes/no
• labour induction yes/no
• previous vaginal delivery yes/no
• estimated fetal weigth >p90 yes/no
This model was tested in a prospective study and indeed showed that the total number of 
vaginal deliveries did not change, but a shift from unplanned to planned CS was observed. 
Women without a prior CS: Unplanned (emergency) CS
In the group of women without a previous CS, those who end up with a (possibly unnecessary) 
CS are mostly nulliparous women with the intention of a vaginal delivery. In total, this group 
comprises about 40% of the obstetrical population (SIMPLE study population). Unplanned 
(emergency) CS occurs mainly in nulliparous women. In multiparous women, occasionally a 
CS is performed during labour but this is mainly due to infrequently occurring situations like 
cord prolapse or instable position of the foetus [11]. It is unlikely that an intervention will 
substantially change the quality of care in multiparous women. 
• Non reassuring foetal condition
‘Suspected foetal distress’ is one of the most frequently occurring indicators associated 
with unplanned CS. Although guidelines in many countries in Europe advise additional 
testing, e.g. foetal blood sampling (FBS), in case of a non-reassuring foetal heart 
rate tracing, this is not the case in the United States due to lack of evidence [12-14]. 
Furthermore, after this study, the results of several STAN analysis trials (i.e., use of 
foetal ECG) showed no effect on the CS rates. The positive effect of FBS has also only 
been indirectly demonstrated [15]. Therefore, the lack of evidence, as also mentioned 
by some caregivers, combined with the fact that FBS is an invasive, technically difficult 
procedure with a relatively high failure rate, might contribute to its relatively low uptake 
[3].
Improving guideline adherence may require a more solid proof that this actually reduces 
CS rates. The use of lactate in case of FBS might reduce the technical difficulties. This is 
a very promising alternative [16].
• Failure to progress
The second largest group of women in whom guideline adherence is low is the group of 
women in which a CS is performed for failure to progress. In our study, in more than 75% 
not all recommendations were followed before a CS was performed. In 2010, Wassen 
et al. described in NTOG that merely 61% of all hospitals could guarantee epidural 
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anaesthesia within one hour [17]. Currently, 24h-availability of epidural anaesthesia is 
one of the Dutch quality indicators for obstetrical care [18]. A second point of concern 
in case of failure to progress is, like in the situation of non-reassuring foetal condition, 
the lack of solid evidence. Although the Friedman chart is used, it dates from the 1950s 
and the evaluation of outcome is lacking [19,20]. The ACOG and RCOG adjusted the 
recommendations in which an even longer expectative management is advocated 
[21,22]. 
As a result of the current data, we started the SIMPLE III study in The Netherlands in 
which, at the crossing of the Friedman action line, women were randomized between 
an immediate CS and a longer expectative management. This study was prematurely 
ended due to failure to include an adequate number of women because of hospitals 
declining participation. Some hospitals were convinced that prolonged expectative 
management was absolutely preferable, and others were convinced that an immediate 
CS was the preferred choice of action. Furthermore, women showed a clear preference 
for expectative management. More than 90% of women that refused to be randomized 
stated that they preferred to wait longer, provided that the foetal condition was 
reassuring. The next step that will be taken is the development of two prediction models, 
in which both the chances of vaginal delivery, and the risks for relevant morbidity can be 
estimated. We are currently studying which morbidity is considered more relevant than 
a CS by both women and caregivers. The models, possibly combined with a decision aid, 
can improve counselling and decision making in case of non-progressing labour. 
• Continuous support during labour
The indicator that all women should be offered continuous support during labour was 
based on a Cochrane review showing a lower CS rate in women who received one on 
one support and the report ‘a good start’ by a national steering committee on pregnancy 
and childbirth in 2009 [23,24]. This is a document advising on improvement of care in 
the Dutch obstetrical system. Continuous support during labour may improve outcome 
for women and infants. It is associated with increased spontaneous vaginal birth and 
shorter duration of labour. 
Furthermore, continuous support is reported to decrease CS rate, instrumental vaginal 
birth, use of any analgesia, use of regional analgesia, low five-minute Apgar score and 
negative feelings about childbirth experiences. However, the effects might depend on 
the availability of epidural analgesia, settings where women are not permitted to have 
companions of their choice during labour, and in middle-income country settings [25]. 
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We showed in our study that in a large majority of women continuous support could 
not be offered by their obstetrical caregivers in hospital births. Barrier analysis showed 
a lack of adequate staffing to be the main problem [2]. Midwifery-led births might have 
a higher adherence, but a pilot study on continuous care by the KNOV in 2013 showed 
that even in first line care, continuous care in the current setting is not feasible due to 
inadequate availability of caregivers [26]. In the Limburg area we are trying to tackle the 
problem by a ZONMW funded study by adding “kraamverzorgenden” both in first and 
second line care to implement continuous care. Although harm is unlikely, the question 
on cost effectiveness remains relevant. 
Methodological considerations
A strong point of our study is that we included 21 different types of hospitals in several 
regions in The Netherlands, analysing more than 1000 women per group in order to 
determine actual care. When comparing the data from our study to data from the Foundation 
Perinatal Registration The Netherlands (PRN), we conclude that the CS rate is comparable 
(22,2% versus 23,4%) with a similar distribution of planned and unplanned CS (11,4%, 10,8% 
versus 10,5%, 12,9% respectively) [27]. Hence, we expect that the data set is representative 
for The Netherlands. Furthermore, we applied the RAND-modified Delphi method which 
offers a systematic approach to indicator development and is a frequently used method 
that has proven to result in valid quality indicators [28]. We therefore consider the indicator 
set appropriate for measurement of actual obstetrical practice in the Dutch setting. Its 
international applicability is questionable since we did not involve international experts 
when developing the indicator-set. Thus, before applying the indicators internationally, 
interpretation of the indicator-set by a local expert panel is a necessary step.
A factor that may impair our study is the method of data collection. The data collection from 
medical charts was performed retrospectively by trained research nurses from the Dutch 
consortium, which could introduce bias. It was shown by Luck et al. that medical chart review 
somewhat underestimates the actual care given, thereby underestimating adherence [29]. 
Not every detail of a consultation is noted in the medical chart. Bias due to misinterpretation 
from medical charts is a possibility, although data extraction was performed by trained 
research nurses. However, when considering the adherence percentages for the main 
categories (fetal distress, non-progressive labour and previous CS) in our study, we do not 
expect our results to change substantially. 
For our barrier analysis study, we invited different types of obstetric healthcare providers 
that might have an influence on the offered CS care: obstetricians, residents and midwives, 
respectively. Professionals from different types of hospitals and private practices from 
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different Dutch regions participated to this study, thereby representing all different elements 
of Dutch obstetrical care. The different types of healthcare providers were interviewed 
separately, in order to let them speak without restraint. The main barriers and facilitators 
were frequently mentioned among all different types of professionals, suggesting that the 
identified barriers are useful for the development of a new implementation strategy. Since 
analysis of interviews is prone to interpretation bias, all interviews were interpreted by two 
independent reviewers, based on the theoretical model by Grol [30-31]. The influencing 
factors were identified using a qualitative, explorative method, therefore no quantitative 
conclusions can be justified by this method. 
Our study was performed in a national setting, based on an indicator set developed for 
measuring Dutch obstetrical practice. Although national and international guidelines formed 
the basis of the indicator set, we identified some facilitators and barriers that are typical 
for the Dutch system, concerning the collaboration between first and secondary care. 
However, it is in line with literature that barriers exist specific to regional habits and practice 
[32,33]. With international guidelines as a basis, we consider most results to be potentially 
relevant for international use, since our results describe the availability of equipment and 
staff, acceptance of guidelines and women’s motivations to be of influence in line with 
literature.          
     
The study on external validation of two prediction models was performed in a multicentre 
setting, with a good representation of different types of hospitals in different regions in The 
Netherlands. A limitation to our study is the handling of missing data in our data set. There 
was only a small quantity of missing data for most variables and we considered it to be missing 
at random. Thus, we were able to limit loss of data by using a multiple imputation strategy. A 
multiple imputation strategy has shown to be superior to a complete case analysis, because 
complete case analysis results in a large loss of power and might induce biased parameter 
estimates [34,35].
Conclusion
This thesis formed a solid basis for the improvement of care for large groups of women. We 
were able to define relevant subgroups and develop improvement strategies. Studies on the 
effects of these strategies are on-going and promising. 
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Dit hoofdstuk beschrijft het maatschappelijk belang van de onderzoeken uit dit proefschrift 
en hoe deze van invloed zijn op de zwangere in het bijzonder.
Relevantie
Wereldwijd wordt een stijging van het aantal keizersneden waargenomen. In Nederland is 
het percentage keizersneden de laatste jaren stabiel rond de 15%. Hierbij is echter opvallend 
dat de meeste keizersneden plaatsvinden bij de ‘gezonde’ zwangere: vrouwen zwanger van 
hun eerste kind in hoofdligging na 37 weken [1,2]. Deze stijging gaat niet gepaard met een 
verbeterde gezondheid voor moeder of kind, sterker nog , de keizersnede heeft ook nadelen. 
Ten opzichte van een vaginale baring leidt een keizersnede tot een toegenomen kans op 
complicaties, niet alleen voor de huidige, maar ook voor een daarop volgende zwangerschap 
[3-6]. Daarnaast zijn de kosten van een keizersnede hoger dan de kosten van een vaginale 
baring.
Doelgroep
Zowel de Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG) als andere 
internationale verenigingen hebben richtlijnen opgesteld, waarin de indicaties voor een 
keizersnede worden beschreven. Het is echter de vraag of deze richtlijnen voldoende 
gevolgd worden. In hoofdstuk 3 staat het proces beschreven van de ontwikkeling van 
kwaliteitsindicatoren rondom een keizersnede. De kwaliteitsindicatoren hebben niet alleen 
betrekking op de indicatiestelling voor een keizersnede, maar ook op maatregelen die de 
kans op een keizersnede verkleinen. Deze indicatoren staan voor optimale zorg en maken 
deze daadwerkelijk meetbaar. Vervolgens is aan de hand van de kwaliteitsindicatoren de 
huidige zorg gemeten. Uit de analyse blijkt dat de adviezen uit de kwaliteitsindicatoren 
niet altijd gevolgd worden. Hierbij zijn 4 groepen zwangere vrouwen naar voren gekomen, 
waarbij de kwaliteitsindicator frequent voorkomt en de naleving van de kwaliteitsindicator 
relatief laag is:
1. Vrouwen met een voorgaande keizersnede
2. Vrouwen zwanger van een eerste kind met vermoeden op foetale nood
3. Vrouwen zwanger van een eerste kind waarbij de baring niet vordert
4. Continue begeleiding van de baring
De verwachting is dat een verbeterstrategie gericht op deze 4 groepen de grootste invloed 
heeft op de mogelijke verbetering van de zorg. Omdat de gegevens van meerdere ziekenhuizen 
zijn geanalyseerd, is dit onderzoek representatief voor de Nederlandse bevolking. Daarmee is 
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te verwachten dat de verbeteringen van invloed zijn op alle Nederlandse zwangere vrouwen.
In hoofdstuk 5 beschrijven we de classificatie van de SIMPLE studie populatie volgens het 
classificatie systeem van Robson [7]. Dit systeem maakt gebruik van 10 groepen, waarin alle 
zwangere vrouwen kunnen worden ingedeeld. Het doel van een dergelijke indeling is om 
vergelijking van keizersnede percentages tussen ziekenhuizen, regio’s of landen mogelijk te 
maken. Bij de indeling komen twee groepen naar voren die de grootste bijdrage leveren aan 
het percentage keizersneden:
A. Vrouwen zwanger van een eerste kind in hoofdligging vanaf 37+0 weken;
B. Vrouwen met een eerdere keizersnede in het verleden.
Het voorkómen van de eerste keizersnede en de juiste voorlichting aan de zwangere met een 
eerdere keizersnede zijn daarom van groot belang. In hetzelfde hoofdstuk staat een voorstel 
beschreven om inhoud toe te voegen aan de vergelijking van keizersnede percentages. 
Als duidelijk is dat de twee bovenstaande groepen de belangrijkste bijdrage leveren aan 
het percentage keizersneden, kunnen kwaliteitsindicatoren van de SIMPLE studie worden 
toegevoegd aan de analyse. Zodoende omvat de analyse de volgende groepen:
A. Het percentage vrouwen met een eerste kind in hoofdligging vanaf 37+0 weken waarbij 
een ongeplande keizersnede wordt uitgevoerd vanwege niet vorderen van de baring 
waarbij sprake is van:
- Gebroken vliezen, adequate pijnstilling en adequate contracties gedurende 4 uur
- Actief persen in het stadium van de uitdrijving, en indien mogelijk een kunstverlossing 
is aangeboden;
B. Het percentage vrouwen met één voorgaande keizersnede en een eenling in hoofdligging 
vanaf 37+0 weken die adequaat voorgelicht zijn over alle voor- en nadelen van een 
geplande keizersnede en vaginale baring na een eerdere keizersnede en een keuze 
hadden in de manier van bevallen.
Door de toevoeging van kwaliteitsindicatoren aan het classificatiesysteem van Robson is 
niet alleen internationale vergelijking van keizersnede percentages mogelijk, maar is ook 
vergelijking van de inhoud van de zorg mogelijk. Als uit een dergelijke analyse blijkt dat het 
percentage keizersneden verhoogd is, kan, na analyse van factoren die van invloed zijn op de 
zorg, een verbeterstrategie worden ontwikkeld. Door deze aanpak kan de zorg voor zwangere 
vrouwen internationaal worden bevorderd.
Innovatie
De SIMPLE studie is de eerste studie die een set kwaliteitsindicatoren heeft ontwikkeld met 
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betrekking tot het gehele verloskundige proces rondom de keizersnede. Hierbij zijn zowel 
de indicatiestelling beschreven, als maatregelen die de kans op een keizersnede verlagen. 
Doordat factoren worden meegenomen die voor aanvang van de bevalling van invloed zijn 
op de besluitvorming (bv stuitligging), tijdens een bevalling (bv niet vorderen van de baring), 
en na de bevalling (bv het opzetten van een audit mbt keizersneden), kan de kwaliteit van 
het hele zorgproces worden gemeten. Tevens zijn factoren bepaald die belemmerend of 
bevorderend kunnen werken bij het volgen van de kwaliteitsindicatoren, zodat het mogelijk 
is om een aangepaste verbeteringsstrategie te ontwikkelen.
Implementatie
De implementatie wordt beschreven aan de hand van de 4 groepen van zwangere vrouwen 
die zijn geïdentificeerd in hoofdstuk 3 van dit onderzoek.
1. Vrouwen met een voorgaande keizersnede
De Nederlandse richtlijn gaf aan dat vrouwen met een voorgaande keizersnede 
geïnformeerd dienen te worden over hun keuze, de kans op complicaties, zoals een 
scheur in de baarmoeder en de kans op succesvolle vaginale baring. In hoofdstuk 4 
staat beschreven dat zorgverleners terughoudend zijn om vrouwen te betrekken bij deze 
beslissing uit vrees voor een toename in het percentage keizersneden. Een nadeel van 
deze voorlichting is dat wordt uitgegaan van een algemeen slagingspercentage voor 
vaginale baring na een eerdere keizersnede. In hoofdstuk 6 staat de validatie van 2 
voorspellingsmodellen beschreven, die een individuele kans van slagen geven, rekening 
houdend met persoonlijke kenmerken. Dit geeft een betere risicoselectie voorafgaand 
aan de baring. Deze modellen hebben een goed voorspellend vermogen, echter het 
is noodzakelijk om het model te valideren in een prospectieve studie. Daarnaast is 
het opstellen van een keuzehulp een volgende stap om de voorlichting voor vrouwen 
na een eerder keizersnede te verbeteren. De combinatie van gestandaardiseerde 
voorlichting middels een keuzehulp die leidt tot een geïndividualiseerde inschatting van 
de kans van slagen van een vaginale baring na een keizersnede kan voordelen bieden 
voor zorgverlener en zwangere. Het effect op de zwangerschapsuitkomst, evenals de 
tevredenheid van zorgverlener en patiënt is in een prospectief onderzoek bestudeerd 
[8]. Hierbij is een gelijk percentage keizersnede waargenomen, met een verschuiving 
van ongeplande keizersneden naar geplande keizersneden. Dit wijst op een betere 
risicoselectie voorafgaand aan de baring.
2. Vrouwen zwanger van een eerste kind met vermoeden op foetale nood
Alhoewel richtlijnen aanvullende diagnostiek in de vorm van microbloedonderzoek of 
STAN analyse adviseren, is er onvoldoende bewijs voor een verbeterde uitkomst. Na 
110 
8
CHAPTER 8
de totstandkoming van de kwaliteitsindicatoren uit dit onderzoek, tonen diverse trials 
dat het gebruik van STAN geen invloed heeft op het percentage keizersneden dat 
wordt uitgevoerd. Voor het positieve effect van microbloedonderzoek bestaat slechts 
indirect bewijs [9-12]. Het gebrek aan bewijsvoering in combinatie met een tijdrovende, 
invasieve en technisch ingewikkelde procedure kan een verklaring zijn voor de lage 
adherentie. Om de naleving van deze kwaliteitsindicator te verbeteren is een onderzoek 
naar de effectiviteit van het microbloedonderzoek noodzakelijk. De toepassing van 
lactaat analyse bij het microbloedonderzoek kan de procedure vergemakkelijken [13]. 
Hierbij is een kleinere hoeveelheid bloed nodig, waardoor de kans van slagen mogelijk 
toeneemt. Een combinatie van verbeterde bewijsvoering en een eenvoudiger procedure 
kan de zorg in geval van verdenking foetale nood verbeteren.
3. Vrouwen zwanger van een eerste kind waarbij de baring niet vordert
Om de zorg voor deze groep zwangere vrouwen te verbeteren wordt adequate 
pijnstilling geadviseerd. De beschikbaarheid van de ruggenprik 24 uur per dag is een 
Nederlandse kwaliteitsindicator voor Medisch Specialistische Zorg [14]. Ook in het 
geval van deze indicator is er onvoldoende bewijsvoering wat betreft de diagnose ‘niet 
vorderen van de baring’. De Friedman curve die wordt gebruikt om de vordering van 
de baring in kaart te brengen dateert uit 1950 en is onvoldoende gevalideerd [15,16]. 
De gynaecologen verenigingen in Groot-Brittannië en de Verenigde Staten promoten 
een langere periode van afwachten onder optimale condities dan bij de Friedman curve 
[17,18]. Naar aanleiding van deze gegevens is een volgende SIMPLE studie gestart die 
vrouwen in geval van niet vorderen van de baring randomiseert tussen een keizersnede 
en een verlenging van de periode waarin wordt afgewacht. Deze studie is tussentijds 
beëindigd vanwege een gebrek aan inclusies. Hieraan lag ten grondslag dat diverse 
zorgverleners en patiënten een specifieke voorkeur uitspraken voor een keizersnede of 
een afwachtend beleid. Meer dan 90% van de vrouwen gaf aan de voorkeur te geven 
aan een afwachtend beleid zolang er sprake was van een goede foetale conditie. Als 
volgende stap zou de ontwikkeling van een voorspellingsmodel voor de kans van slagen 
van een vaginale baring in geval van niet vorderen van de baring een toevoeging zijn. Dit 
model, wellicht in combinatie met een keuzehulp waarin de kans op morbiditeit wordt 
beschreven, kan zorgverleners en patiënten helpen bij het maken van hun keuze.
4. Continue begeleiding van de baring
Continue begeleiding van vrouwen tijdens de baring wordt geadviseerd in het rapport 
‘een goed begin’, opgesteld door een nationale Stuurgroep Zwangerschap en Geboorte 
[19]. Continue begeleiding verkleint de kans op een keizersnede en een vaginale 
kunstverlossing. Daarbij is aangetoond dat de pijnstillingsbehoefte afneemt en de 
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zwangere positiever terugkijkt op haar bevalling [20]. Een gebrek aan personeel en 
financiën zijn de grootste belemmeringen voor het uitvoeren van deze kwaliteitsindicator. 
In Limburg is een zonMW studie gestart waarbij kraamverzorgenden worden ingezet 
voor continue begeleiding tijdens de baring. Hierbij wordt gerandomiseerd tussen 
gebruikelijke zorg en continue begeleiding van de barende en wordt het effect op onder 
andere pijnstillingsbehoefte en percentage keizersneden beoordeeld. Daarnaast wordt 
de kosteneffectiviteit beoordeeld.
Met deze studie is een basis gelegd voor verbetering van zorg voor zwangere vrouwen. Er zijn 
diverse projecten opgestart om de effecten van de implementatiestrategieën te evalueren.
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Achtergrond en doel van het onderzoek 
De keizersnede (sectio caesarea: SC) is bedoeld als levensreddende operatie voor moeder 
en kind. Er zijn richtlijnen ontwikkeld die aangeven voor welke indicaties deze ingreep kan 
worden uitgevoerd. De wereldwijde stijging van het SC percentage en de variatie daarin kan 
erop wijzen dat deze operatie niet altijd juist wordt ingezet. Een SC heeft gevolgen voor een 
volgende zwangerschap en gaat gepaard met hogere kosten. 
Dit proefschrift richt zich op verbetering van zorg rondom de SC. Het doel van dit onderzoek 
was om groepen vrouwen te identificeren, waar de zorg in hoge mate niet in lijn was met 
wetenschappelijke richtlijnen en waar verbetering van zorg waarschijnlijk (kost)effectief en 
haalbaar is. Hiertoe is allereerst optimale zorg rondom de SC gedefinieerd obv richtlijnen. 
Vervolgens is de naleving van optimale zorg gemeten en bepaald welke groep vrouwen 
meest waarschijnlijk baat zou hebben bij een verbeteringsstrategie. In de volgende stap is 
bepaald welke factoren bijdragen aan het bevorderen of belemmeren van optimale zorg en 
met name welke (medische en niet-medische) factoren de kans op een ongeplande (spoed) 
SC bij nullipare vrouwen beïnvloeden. Met deze inzichten zijn strategieën ontwikkeld om de 
zorg rondom de SC te verbeteren. Deze stappen worden in dit hoofdstuk beschreven. 
Belangrijkste bevindingen
Hoofdstuk 1 bevat een algemene introductie en een uiteenzetting van de inhoud van dit 
proefschrift. De SC is wereldwijd een van de meest uitgevoerde operaties bij vrouwen. Hoewel 
ooit als levensreddende ingreep ingevoerd, wordt nu bediscussieerd dat de toegenomen 
incidentie mogelijk een negatief effect op de gezondheid van moeder en kind kan hebben.
Hoofdstuk 2 beschrijft het studie protocol van de SIMPLE studie (cesarean Section 
IMPLEmentation) met de volgende onderwerpen: 1) De ontwikkeling van kwaliteits-
indicatoren rondom de besluitvorming tot een SC, gebaseerd op kernaanbevelingen van 
nationale en internationale richtlijnen; 2) het gebruik van deze indicatoren om inzicht te 
krijgen in de mate waarin zorgverleners in de dagelijkse praktijk werken volgens de richtlijnen 
(richtlijnadherentie); 3) het bepalen van belemmerende en bevorderende factoren die de 
richtlijnadherentie beïnvloeden; 4) het ontwikkelen, uitvoeren en evalueren van een strategie 
om de richtlijnadherentie te verbeteren. Met de uitkomsten van de studie worden groepen 
vrouwen geïdentificeerd waarbij een interventiestrategie om de zorg te verbeteren (kost)
effectief en haalbaar zal zijn. In de hoofdstukken 3 en 4 worden de studies, gericht op de 
eerste 3 onderwerpen, uitgebreid beschreven. Het ontwikkelen van een interventie-strategie 
vormt geen onderdeel van dit proefschrift.
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Hoofdstuk 3 beschrijft de ontwikkeling en meting van op de richtlijnen gebaseerde kwaliteits-
indicatoren rondom de SC zorg in Nederland. Achttien gynaecologen en verloskundigen 
vormen een expertpanel waarbij een systematische ontwikkeling van indicatoren volgens de 
RAND-modified Delphi methode is verricht. In een multicenter onderzoek zijn de indicatoren 
gemeten aan de hand van dossiers van 1024 vrouwen met een SC en een gestratificeerde en 
gewogen random geselecteerde groep van 1036 vrouwen met een vaginale baring. Zowel het 
voorkomen van de situatie (bv. stuitligging, niet vorderen van de baring), zoals beschreven 
in de kwaliteitsindicatoren (frequentie) als de adherentie aan de indicatoren zijn bepaald. In 
totaal zijn 16 indicatoren rondom een geplande SC en 11 indicatoren rondom een ongeplande 
SC ontwikkeld en gemeten. Adherentie is gedefinieerd als het percentage vrouwen waarbij 
de zorg zoals beschreven in de indicator daadwerkelijk is verleend. De meest voorkomende 
groepen met een lage adherentie zijn: 1) verdenking foetale nood (frequentie voorkomen 
17%, adherentie 46%), 2) niet vorderende baring (frequentie voorkomen 12%, keizersnede te 
vroeg ingezet > 75%), 3) continue begeleiding tijdens de baring (frequentie voorkomen 88%, 
adherentie 37%) 4) vrouwen met een eerdere SC (frequentie voorkomen 12%, adherentie 
adequate counseling 15%). 
Hoofdstuk 4 beschrijft de belemmerende en bevorderende factoren rondom SC zorg 
vanuit het perspectief van de zorgverlener. Zowel focusgroep interviews als telefonische 
interviews onder 29 verschillende obstetrische zorgverleners zijn verricht. De factoren zijn 
geïdentificeerd en gecategoriseerd in zes domeinen volgens het framework van Grol & 
Wensing: de richtlijn zelf, de professional, de patiënt, de sociale context, de organisatorische 
context en de financiële/juridische context. De meeste belemmerende factoren zijn in het 
professionele en organisatorische domein gevonden. Zorgverleners kunnen zich op sommige 
onderdelen van de richtlijn niet in de inhoud vinden en er bestond aarzeling om vrouwen deel 
te laten nemen aan het besluitvormingsproces. Overige belemmerende factoren betreffen 
een gebrek aan getraind personeel, onvoldoende samenwerking tussen zorgverleners uit 
verschillende disciplines en een gebrek aan materieel. Een aantal belemmerende factoren 
kan worden opgelost door de ontwikkeling van een keuzehulp en/of een predictiemodel om 
de zorg te individualiseren voor vrouwen waarbij een SC en een vaginale baring beiden tot 
de mogelijkheden behoren. Bij vrouwen die aan een vaginale baring beginnen, is voldoende 
personeel voor begeleiding en epidurale pijnstilling belangrijk. 
Hoofdstuk 5 beschrijft het SC percentage van de SIMPLE studie populatie na indeling volgens 
het classificatie systeem van Robson. Dit systeem omvat 10 obstetrische groepen waarin alle 
zwangere vrouwen kunnen worden ingedeeld om het SC percentage per groep te bepalen. Dit 
maakt vergelijking van SC percentages mogelijk per ziekenhuis, regio of land. De subgroepen 
met de belangrijkste bijdrage aan het SC percentage zijn: 1) nullipare vrouwen met een 
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eenling in hoofdligging na 37 weken, 2) vrouwen met een voorgaande SC met een eenling 
in hoofdligging na 37 weken en 3) vrouwen met een inleiding of geplande SC (bijdrage aan 
SC percentage respectievelijk 17%, 24% en 14%). Dit geeft aan dat het voorkomen van de 
eerste SC van groot belang is. Dit classificatie systeem is hiermee een eerste indicatie voor 
de identificatie van subgroepen met een (relatief) hoog SC percentage. Om meer inhoud aan 
de vergelijking van SC percentages in deze groepen te bewerkstelligen, is ons voorstel om 
een analyse van SIMPLE kwaliteitsindicatoren toe te voegen aan de groepen die het meest 
bijdragend zijn aan het SC percentage.
Hoofdstuk 6 beschrijft de externe validatie van twee predictiemodellen ontwikkeld in de 
Verenigde Staten voor vrouwen na een eerdere SC om de kans op een geslaagde vaginale 
baring te voorspellen. In een cohort van 763 vrouwen met één SC in het verleden en een 
eenling in hoofdligging in de huidige zwangerschap zonder contra-indicatie voor een vaginale 
baring zijn twee bestaande modellen gevalideerd voor de Nederlandse populatie: het 
entry-to-care [ETC] en close-to-delivery [CTD] model. Het ETC model bevat de variabelen 
leeftijd, BMI, etniciteit, eerdere vaginale bevalling, eerdere vaginale bevalling na een SC 
en een voorgeschiedenis van een niet vorderende baring. Het CTD model vervangt de BMI 
voorafgaand aan de zwangerschap door de BMI in het derde trimester en voegt geschatte 
zwangerschapsduur bij de bevalling toe, evenals de variabelen hypertensie, cervixstatus 
en inleiding. Met beide modellen is de kans op een succesvolle vaginale baring na eerdere 
SC berekend voor de 763 vrouwen. Vijfhonderdvijftien (67%) van de 763 vrouwen hadden 
een intentie tot een vaginale baring; 371 (72%) van hen bevielen vaginaal. Vervolgens 
is gekeken naar het voorspellend vermogen (precisie) en onderscheidend vermogen 
(onderscheid tussen hoge versus lage kans van slagen) om te beoordelen hoe de modellen 
in dit Nederlandse cohort presteren. De area under the curve (AUC) van het ETC en CTD 
model zijn respectievelijk 68% (95% CI 63-72%) en 72% (95% CI 67-76%), wat een redelijk 
onderscheidend vermogen aangeeft. De Hosmer-Lemeshow toets laat een P-waarde van 
0.17 voor het ETC model en 0.36 voor het CTD model zien, doelend op een redelijke precisie. 
Dit toont aan dat beide modellen adequaat presteren in ons Nederlandse cohort. 
Hoofdstuk 7 beschrijft de algemene discussie van dit proefschrift en biedt suggesties voor 
toekomstig onderzoek. We stellen dat dit proefschrift een basis vormt voor verbetering 
van zorg voor een grote groep vrouwen. We zijn in staat geweest om groepen vrouwen 
te definiëren waar verbetering van zorg mogelijk is en verbeteringsstrategieën ontwikkeld 
worden. De studies naar het effect van deze strategieën zijn veelbelovend. 
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Roumans, bedankt voor het vertrouwen en het inzicht in patiëntenzorg in het algemeen. 
Josje Langenveld, mijn mentor, altijd tijd voor een gesprek over opleiding en onderzoek, 
maar ook op persoonlijk vlak een grote steun. Roy Kruitwagen, bedankt voor de support 
en visie op het vak tijdens de opleiding. Christine Willekes, je unieke visie op de opleiding, 
onderzoek en je persoonlijke interesse zijn bijzonder. Even sparren met jou zorgt altijd voor 
nieuwe ideeën en energie.   
Mijn paranimfen. Imke, wat ben ik blij met alle gesprekken en slechte grappen tijdens de 
opleiding en dit traject. Het was erg leuk om samen te sparren over stellingen voor dit 
proefschrift. Kim, een zondagmiddag bij jullie op de berg is altijd goed. Alles kan besproken 
worden tijdens de koffie of tijdens een barbecue met een wijntje. 
Lieve familie, vrienden en vriendinnen. Bedankt voor alle gesprekken, hulp, oppas, gezellige 
avonden en weekenden – dit heeft me de afgelopen jaren ontzettend geholpen. Zonder jullie 
energie was dit niet gelukt. 
Collega sporters bij Kimbria, een top team en top club om bij te horen. 
Lieve schoonfamilie, Angela, JW, Loes, bedankt voor alle gezelligheid en de welkome afleiding 
in de Achterhoek. Ik kijk uit naar de volgende familiedag! 
Lieve pap en mam, jullie steun, positieve instelling en belangstelling hebben me geholpen 
tot dit punt te komen. Via biomedische wetenschappen en geneeskunde in Leiden naar 
gynaecologie in Maastricht. Jullie staan altijd voor me klaar. Dank jullie wel voor alles. 
Wouter en Yvonne, broertje en schoonzus, bedankt voor de verhelderende gesprekken, humor 
en de gezellige avondjes (liefst met kampvuur). We hebben altijd bitterballen voor jullie in huis! 
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We hebben een bijzondere en intense tijd achter ons, Robin. Je had oneindig vertrouwen in 
me en wist me altijd weer te motiveren. Je bracht een andere kijk op de wereld. Meike en 
Nathan, jullie staan altijd klaar met een gevatte opmerking of een glimlach. Jullie nuchtere 
kijk op de wereld zorgt ervoor dat ik met twee benen op de grond blijft staan. Lieve Michel, 
ik geniet van een nieuwe kijk op de toekomst die je hebt gebracht. De gesprekken met jou, 
jouw liefde en een knuffel maken mijn dag weer goed. 
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een wetenschappelijke stage bij Eurotransplant rondde zij deze studie succesvol af in 2002. 
Daarnaast startte zij in 2000 met de studie Geneeskunde aan de Universiteit Leiden. Na het 
behalen van het artsexamen in 2005 werkte zij als arts niet in opleiding tot medisch specialist 
(ANIOS) verloskunde en gynaecologie in het Reinier de Graaf Gasthuis in Delft (2005-2007) en 
het Maastricht Universitair Medisch Centrum+ (2007-2008). In 2008 startte zij de opleiding 
tot gynaecoloog, waarbij zij zowel in het MUMC+ (opleider: Prof. Dr. R.F.P.M. Kruitwagen, 
plaatsvervangend opleider: Dr. G.A.J. Dunselman) als in het Atrium Medisch Centrum (opleider: 
dr. P.E.A.M. Mercelina, plaatsvervangend opleider: F.J.M.E. Roumen) werkzaam was. Tijdens de 
opleiding startte zij met de SIMPLE studie zoals beschreven in dit manuscript. De specialisatie 
Obstetrie en Gynaecologie rondde zij af in 2016, waarna zij werkzaam was in het Zuyderland 
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